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Bacillus subtilis, the model organism for Gram-positive bacteria, expresses seven 
extracytoplasmic function (ECF) σ factors (called σM, σW, σX, σY, σV, σZ and σYlaC). 
σM, σW, σX, and σV are well-characterized and mediate cell envelope stress responses. 
The functions of σY, σZ and σYlaC remain largely unknown. One challenge in 
understanding the regulatory roles of ECF σ factor is that they display significant 
redundancy in their regulons.  
 In this study, we investigate the regulation of B. subtilis antibiotic production 
and resistance by ECF σ factors using both global analytical techniques (cDNA 
microarrays, phenotypic arrays, and transposon mutagenesis) and classical genetic and 
physiological tests. This work began with the observation that a triple sigMWX mutant 
(strain ΔMWX) lost its ability to inhibit the growth of other bacilli strains. We present 
evidence that deletions of σX and σM underlie this phenotype and that in wild type cells 
these ECF σ factors activate the expression of a transcription factor Abh. Abh 
stimulates the production of a peptide antibiotic called sublancin, which is able to 
inhibit the growth of other bacilli. We also compared the transcriptomic profiles and 
phenotypic traits of strains lacking these three σ factors (ΔMWX) and all 7 ECF σ 
factors (Δ7ECF) with a wild type strain. Deletion of all 7 ECF σ factors affects the 
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transcriptions of over 80 genes, most of which are regulated by σM, σW, or σX. The 
ΔMWX and Δ7ECF strains are more sensitive to several cell envelope disrupting 
compounds when compared to wild type including two β-lactam antibiotics 
(aztreonam and cefuroxime). Finally, we investigated the ECF σ factor-dependent 
genetic and biochemical mechanisms that mediate resistance to cefuroxime. σM is the 
major determinant in cefuroxime resistance with σX playing a smaller role. These σ 
factors regulate at least three pathways involving the regulatory proteins Abh and Spx, 
and a cyclic-di-AMP synthase DisA. Collectively, the data in this work suggests that 
ECF σ factors regulate an intricate regulatory network that contributes to both 
antibiotic production and resistance in B. subtilis. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Bacillus subtilis and its cell envelope structure and synthesis 
Bacillus subtilis, a ubiquitous soil bacterium, has a typical Gram-positive cell 
envelope structure: a cell membrane surrounded by a thick peptidoglycan (PG) layer 
and associated anionic polymers (39, 113) (Figure 1.1). The cell envelope plays a vital 
role for cell growth. It maintains cell shape, counteracts turgor pressure, and transports 
molecules in and out of the cell (54, 135). It is thereby a prime target for antibiotics 
(137). 
The cell membrane of B. subtilis consists of anionic phospholipids 
(phosphatidylglycerol and cardiolipin), neutral lipids (glycolipids and 
phosphatidylethanolamine), and a small percentage of a positively charged 
phospholipid (lysyl-phosphatidylglycerol) (27,30,117). It has a net negative charge 
and is therefore a target for cationic antimicrobial peptides (CAMP). B. subtilis also 
contains teichoic acids (TA) that are either membrane-associated (lipoteichoic acid, 
LTA) or PG-bound (wall teichoic acid, WTA) (Figure 1.1). LTA and WTA are 
individually dispensable but collectively these anionic polymers are essential (39). 
There are few antibiotics known to target TA biosynthesis, but a small molecule 
targocil was recently discovered to inhibit the growth of Gram-positive 
Staphylococcus aureus by sequestering the WTA transporter TagGH (111, 124).  
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The PG layer is often referred to as the cell wall in B. subtilis. It is a network 
of glycan strands consisting of repeating disaccharide units of N-acetylglucosamine 
(GlcNAc) and N-acetylmuramic acid (MurNAc), that are cross-linked by peptide side 
chains. PG biosynthesis starts with a stepwise conversion of Uridine diphosphate-N-
acetylglucosamine (UDP-GlcNAc) to Uridine diphosphate-N-acetylmuramic acid 
(UDP-MurNAc)-pentapeptide (Figure 1.2). In B.subtilis, the pentapeptide consists of 
L-Ala-D-Glu-mDAP-D-Ala-D-Ala. The UDP-MurNAc)-pentapeptide is then 
covalently bonded with the membrane-bound undecaprenyl-phosphate to form Lipid I. 
GlcNAc is attached to Lipid I, producing Lipid II. Lipid II is translocated to the 
extracytoplasmic face, where the GlcNAc-MurNAc-pentapeptide is incorporated into 
the nascent PG strand by the activity of transglycosylase (TG). Concurrent with or 
soon after polymerization, the pentapeptide side chain is cross-linked by 
transpeptidase (TP). The cross-linking peptide bond is usually formed between the 3rd 
(mDAP) and the 4th (D-Ala) amino acids in the adjacent PG strand sidechains. Both 
TG and TP are activities of high molecular weight penicillin binding protein (HMW 
PBP), and they are the targets of moenomycin and β-lactam antibiotics, respectively. 
Many of the PG synthesis enzymes and intermediate products are also targets of 
antibiotic action (Figure 1.2). The glycan strand adopts a right-handed helix-like 
conformation, with a periodicity of three disaccharide units (per turn of the helix), and 
the peptide side chains extend radially from the glycan strand. Many (but not all) side 
chains of adjacent glycan of the strands are cross-linked, creating a three-dimensional, 
stress bearing meshwork of strands (10, 39, 83).The degree of cross-linking varies in 
different strains and growth conditions. About 29-33% of PG side chains are cross- 
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linked in the vegetative cells of B. subtilis strain 168 (39). 
PG is also a dynamic polymer structure: glycan strands and peptide cross-links 
can be cleaved by PG hydrolases (autolysins) in order to allow PG maturation and cell  
expansion. In addition, autolysins are important for a variety of cellular functions, 
such as protein secretion, motility, chemotaxis, competence, and sporulation (11, 74, 
109, 115). There are 35 autolysin genes (annotated and putative) found in the genome 
of B. subtilis. Together they specifically hydrolyze almost all the different bonds in PG 
(115, 136). The activities of autolysins are tightly regulated, and their de-regulation 
can cause cellular autolysis.  
The biosynthesis and maturation of PG do not occur as isolated events. Instead, 
they are mainly organized by two sets of cytoskeletal machineries: one is scaffolded 
by the actin-like protein MreB, and is primarily dedicated to the lateral cell wall 
synthesis; the other is coupled with tubulin-like protein FtsZ at the mid cell and is 
involved in cell division (Figure 1.3). Multiple studies using fluorescence microscopy 
suggest that MreB forms one continuous helical filament along the length of the cell 
(23, 24, 28, 31, 61, 64, 128). MreB and its homologs (Mbl and MreBH) recruit and 
interact with, directly or indirectly, proteins involved in cell shape determination (e.g. 
RodA, MreC, MreD), PG biosynthesis and hydrolysis (e.g. Mur, PBP1, PBP2a, PbpH, 
and LytE) and TA biosynthesis (e.g. TagU and TagT), and thereby organize PG and 
TA synthesis in the lateral cell wall. However, recent works using high resolution 
imaging techniques proposed a different model (32, 42, 133, 134, 140): MreB and its 
associated proteins form discrete patches, instead of a long helical filament. This  
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MreB complex moves circumferentially around the long axis of the cell while 
organizing PG synthesis on-site. This movement is bidirectional, and is driven by PG 
synthesis. FtsZ, on the other hand, forms a constricting ring at mid cell and recruits 
over a dozen of proteins to the divisome (Figure 1.3). These proteins carry out the 
functions of preseptal elongation, septum formation and cell separation (37, 102). 
 
1.2 Antibiotics target at the cell wall 
1.2.1 Cell wall biosynthesis as antibiotic target pathway 
Because of its crucial role, the cell wall is a prime target for antibiotics (114, 137) 
(Figure 1.2). These antibiotics can either directly inactivate the biosynthetic enzymatic 
activity or sequester required substrates. Here, a selection of antibiotics related to the 
studies in the later chapters will be discussed in more detail, with emphasis on the 
mode of action and the resistance mechanisms employed by bacteria. 
 
β-lactam antibiotics 
β-lactam antibiotics are characterized by the presence of a β-lactam ring (Figure 1.4). 
Since the historical discovery of penicillin in the soil fungus Penicillium chrysogenum 
by Fleming in 1929, a variety of β-lactam antibiotics have been discovered and 
developed. They are now the most widely used antibiotics in medicine (38, 71). β-
lactam antibiotics usually target the penicillin binding domain of PBPs, which are  
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transpeptidases or carboxypeptidases involved in PG cross-linking and maturation 
(Figure 1.2). β-lactam structurally mimics the D-Ala-D-Ala dipeptide substrate of PBP 
(79) (Figure 1.4). A serine residue at the catalytic domain of PBP attacks the carbonyl 
carbon atom of the β-lactam ring, forming a stable acyl-enzyme complex. This β-
lactam-enzyme complex is hydrolyzed at a very slow rate, effectively preventing 
further transpeptidation reactions (110, 146).  
Based on studies using the Gram-positive genera Staphylococcus and 
Streptococcus, and the Gram-negative species Escherichia coli and Pseudomonas spp., 
the major resistance mechanisms towards -lactams are believed to be the following: 
(i) expression of β-lactamase(s) that inactivate the antibiotics; (ii) expression of 
mutated or mosaic PBP alleles that have low affinity for β-lactams; and (iii) the 
expression of a β-lactam specific pump (97, 143). However, these three mechanisms 
cannot be applied or found in the Gram-positive B. subtilis. In chapter 4, we found that 
there are multiple stress response pathways that can contribute the intrinsic resistance 
to β-lactam antibiotics in B. subtilis.  
 
Bacteriocins: lantibiotics and sublancin  
Most antibiotics are natural products (and their derivatives) isolated from soil 
microorganisms (137). The antimicrobial peptides produced in bacteria are often 
referred to as bacteriocins. They are typically potent narrow spectrum antibiotics 
directed primarily against closely related bacteria. 
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 Lantibiotics (lanthionine containing antibiotics) is a major group of 
bacteriocins. They are typical CAMPs containing amphiphilic or hydrophobic regions, 
and hence preferentially interact with the negatively charged cell membrane (25, 144). 
The best studied lantibiotics are nisin (produced by Lactococcus lactis) and mersacidin 
(produced by Bacillus spp. strain HIL Y-85, 54728) (Figure 1.4). Nisin and nisin-like 
molecules such as epidermin (produced by Staphylococcus epidermidis) and subtilin 
(produced by B. subtilis strain ATCC6633) interact with the pyrophosphate of Lipid II, 
and form a lantibiotic-Lipid II complex (Figure 1.2). These complexes aggregate and 
generate defined pores in the membrane, resulting in the leakage of low molecular 
weight compounds (e.g. K+, H+, phosphate), the dissipation of proton motive force 
(PMF), and eventually cell death (15, 57, 93). Mersacidin and related lantibiotics bind 
to both the MurNAc-GlcNAc sugar moiety and the pyrophosphate of Lipid II (14), 
thereby blocking the incorporation of the disaccharide units into PG. Mersacidin and 
most of the mersacidin-like lantibiotics, except plantaricin C, do not form pores at the 
membrane (141).  
 Sublancin 168 is a peptide antibiotic produced by B. subtilis strain 168. It is 
encoded by the sunA-sunT-bdbA-sunS-bdbB operon located in a prophage called SPβ. 
This operon encodes genes for sublancin pre-peptide synthesis, modification and 
transportation. Although originally classified as a lantibiotic (91), sublancin was 
recently identified as a glycopeptide with an unusual S-linked glucose attached to a 
cysteine residue (Cys22) (89) (Figure 1.4). The mode of action for sublancin remains 
unknown, but it is speculated to form pores in a similar manner as nisin. In addition, 
Kouwen et al. (2009) showed that the inhibition of sublancin relies on the presence of 
 11 
a large mechanosensitive ion channel MscL, suggesting that MscL may serve as a 
direct target at the membrane or as a gate of entry to the cytoplasm (72). 
 Immunity to bacteriocins in the producer strain is often provided by its cognate 
immunity genes, which typically encode ABC transporters and/or immunity proteins 
(2). For example, nisin immunity is provided by NisFEG and NisI. NisFEG encode an 
ABC transporter system that exports nisin. NisI is a membrane-bound protein with 
high affinity to nisin, which may sequester nisin, and hence lower the nisin 
concentration and reduce its binding to substrate Lipid II (119, 125). Immunity to 
sublancin is provided by a membrane protein SunI (34). When the glycosylated Cys22 
residue of sublancin was mutated to serine, the producer strain lost its immunity and 
became sensitive to this mutated product, suggesting that the S-glycoside moiety of 
sublancin may be involved in the immunity recognition with SunI (138). The detailed 
immunity mechanism of SunI protein still requires further investigation.  
 In non-producer strains, the major bacteriocin resistance mechanisms are to 
limit the substrate availability, and to express homologs of immunity genes. For nisin 
resistance, cells reduce Lipid II accessibility by modulating membrane negative 
charges. These modifications include coupling the positively charged D-alanine to 
teichoic acid (TA) and increasing the amount of neutral lipid 
phosphatidylethanolamine at the membrane (13). In B. subtilis, these modifications are 
mediated by σX, an extracytoplasmic function σ factor (ECF σ factors are discussed in 
section 1.4.2). In addition, The presence of divalent cations (e.g. Mg2+ and Ca2+) also 
facilitate resistance to nisin, presumably by stabilizing the cell membrane and 
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preventing nisin from reaching the membrane (26). In the case of sublancin, its 
resistance is mediated by the ECF σ factor σW in B. subtilis. This σ factor regulates the 
expression of resistance genes, some of which appear to be homologous to immunity 
genes (18). 
 
1.2.2 The consequences of antibiotic inhibition 
Although the mechanisms of antibiotic-target interactions have been studied in great 
detail, the consequence of this primary interaction at the cellular level is not well 
understood, and remains a subject of investigation. Based on their inhibitory effects, 
antibiotics are generally classified as bactericidal drugs that kill bacteria, and 
bacteriostatic drugs that only inhibit growth (92). Almost all of the cell wall inhibitors 
are bactericidal antibiotics. For example, the inhibition of PBP transpeptidase by β-
lactam causes cell lysis and cell death. Years of research have been focused on this 
lytic effect, and suggest that it is due to increased autolysin activity. Indeed, autolysin-
deficient bacterial strains isolated from either clinical or research laboratories showed 
dramatically reduced rates of cell lysis and increased tolerance to -lactam antibiotics 
(49, 100, 101, 130). How -lactams trigger autolysin activity is still not known but is 
presumed to occur through PBP interaction. Several mechanisms have been proposed 
including an increase in turgor pressure due to continuous cell growth with a non-
expanding cell wall (69), the accumulation of un-crosslinked PG substrate, and the 
depolarization of the membrane potential (94). 
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Autolysin activity is only one aspect of the story. Strains of Streptococcus 
pneumonia and B. subtilis lacking autolysins can still be killed by β-lactams or 
bacteriocins, suggesting that there is a lysis-independent mode of killing (73, 86, 131). 
Recent work from Kohanski et al. (2007), proposed a common mechanism for 
bactericidal antibiotics (not bacteriostatic antibiotics) which is to stimulate hydroxyl 
radical (●OH) formation. They observed a transient depletion of NADH upon 
antibiotic treatment in both E. coli and S. aureus. This was followed by a depletion of 
iron from iron-sulfur clusters and stimulation of internal Fenton reactions, resulting in 
the generation of ●OH (70). ●OH is a highly reactive oxygen species (ROS) that 
introduces oxidative damage to proteins, lipids, and DNA. There is no known enzyme 
to detoxify ●OH, making it extremely toxic (58).  
In Bacillus spp., there are several lines of indirect evidence suggesting that 
ROS are formed upon antibiotic treatment. In B. subtilis, a burst of free radicals was 
detected upon exposure to bactericidal antibiotics such as kanamycin, a protein 
synthesis inhibitor (85). Exposure to the cell wall synthesis inhibitors enduracidin and 
bacitracin induces the expression of numerous Spx-regulated genes (107). Spx is a 
transcriptional regulator that is known to protect cells from ROS stress by inducing 
cytoplasmic thiol production (149). In addition, NO and H2S were also found to 
protect cells from ROS damage imposed by antibiotic (e.g. the β-lactam cefuroxime) 
exposure in Bacillus anthracis, S. aureus, Pseudomonas aeruginosa and E. coli (46, 
112). Although some key aspects of antibiotic-ROS induced cell death were identified, 
the exact pathways and targets involved in ●OH formation remain to be elucidated. 
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1.2.3 Antibiotics as signaling molecules 
Although commonly applied in high doses in medicine, antibiotics may have roles 
other than inhibiting cell growth, especially since their concentrations rarely reach 
high levels in their natural environment (predominantly soil). It has been proposed that 
antibiotics function as signaling molecules for intra- and inter-species communication 
(6, 29, 43, 104). 
At sub-lethal concentrations, antibiotics can modulate global gene expression, 
stimulate cell growth and/or trigger cell differentiation. Tobramycin, an 
aminoglycoside produced by the soil bacterium Streptomyces tenebrarius, was shown 
to induce biofilm formation in P. aeruginosa (52, 75). Similarly, imipenem (a variant 
of the β-lactam thienamycin produced by Streptomyces flavogriseus) induces the 
expression of β-lactamase and promotes the accumulation of alginate, the major 
component of the biofilm matrix in P. aeruginosa (6). A biofilm is a multicellular 
community attached to a surface and encased in an extracellular matrix, where the 
matrix functions as a physical and biochemical barrier to exclude antibiotics (53). Its 
formation may constitute a response to antibiotic stress.  
With regard to intra-species communication, the lantibiotics nisin, subtilin, and 
epidermin have been shown to function as quorum sensing autoinducers and control 
their own biosynthesis in strains of L. lactis, B. subtilis, and S. epidermidis, 
respectively (66, 68). Given the complexity of the soil environment, it is attractive to 
think that antibiotics may have dual activities for signaling within producer strain 
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populations, and for inhibiting competitors. These activities might help cells compete 
for resources and space. 
 
1.3 ECF σ factors and their structure, function and regulation  
Inhibition of cell wall biosynthesis by antibiotics often triggers stress responses inside 
the cell. These responses allow cells to express key proteins which help minimize the 
damage. In Gram-positive bacteria, the cell envelope stress response (CESR) is often 
mediated by two component systems (TCS) and extracytoplasmic function (ECF) σ 
factors (62). Here, I will focus on ECF σ factors.  
 
1.3.1 σ factors and ECF σ factors 
Bacterial RNA polymerase (RNAP) holoenzyme consists of a five subunit core 
enzyme (α2ββ’ω) and a dissociable σ factor (87). The core enzyme is the minimal 
assembly for the catalytic activity of transcription, and σ factors determine promoter 
specificity and stabilize open complex formation in promoter DNA (87). All bacteria 
express one primary σ factor and most bacteria also harbor a variable number of 
alternative σ factors. The primary σ factor is involved in the expression of house-
keeping genes while each alternative σ factor usually activates transcription of a 
specific set of genes in response to environmental cues. Together, σ factors regulate 
gene expression in the cell (7, 48).  
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The bacterial σ factors are divided into two structurally and functionally 
distinct families, σ70 and σ54, both of which are named after the prototypes found in E. 
coli (84, 90, 99). B. subtilis encodes one σ54-like factor (σL) and at least 17 known σ70-
like factors. The σ70-like factors can be further divided into 4 groups based on their 
primary sequence conservation (47, 76) (Figure 1.5). The group 4 σ factors are also 
referred to as extracytoplasmic function (ECF) σ factors, for they often regulate cell 
surface-associated functions such as those related to secretion, transport and 
extracytoplasmic stress (77). These σ factors only retain σ regions 2 and 4, which the 
most conserved regions of all σ factors. These two regions constitute the minimally 
required domains for binding to core RNAP and interacting with the -10 and -35 
motifs of promoter elements (Figure 1.5).  
 The numbers of ECF σ factors in bacteria varies greatly, ranging from zero to 
as many as 83. A high number of ECF σ factors is often associated with a high number 
of TCS and generally reflects the complexity of the environment in which the host 
lives. Bacteria living in a stable condition (e.g. some endosymbionts Chlamydia spp.) 
typically have a small genome and no ECF σ factors. Species living in a diverse and 
variable environment such as soil harbor a relatively high number of ECF σ factors. 
For example, there are 7 ECF σ factors in B. subtilis, 19 in P. aeruginosa, 50-60 in 
Streptomyces coelicolor, and 83 in Sorangium celluosum (116). 
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Figure 1.5. Structural features of σ70 and the interaction between RNAP and promoter 
DNA. (A) The primary sequence of σ70 can be divided into four conserved regions 
(regions 1 through 4). These regions can be further divided into sub-regions. The 
interactions between σ sub-regions and the -35 and -10 elements of a promoter are 
indicated by double arrows. Three structural domains (σ2, σ3 and σ4, dark grey) are 
indicated underneath the linear sequence structure. These domains coordinate closely 
(not precisely) with regions assigned by sequence comparisons. σ factor groups 1 and 
2 contain all 4 sequence regions, group 3 contains regions 2-4, and group 4 (ECF σ 
factor) contains regions 2 and 4. YvrI and YvrHa constitute a two-component σ factor. 
YvrI contains regions of a canonical region 4 and a highly divergent region 2. YvrHa 
contains a σ region 2. NCR, non-conserved region; N, N-terminus; C, C-terminus. (B) 
A schematic illustration for the relative position and function of the major domains of 
an σ factor (dark grey) with the RNAP core and promoter DNA. The arrow indicates 
the direction of transcription. Adapted from (90, 145).  
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1.3.2 The Regulation of ECF σ factors 
As alternative σ factors, ECF σ factors compete with the primary σ factor for RNAP 
core, and redirect RNAP to new promoter sites. Their expression and activity are 
therefore tightly regulated. Studies on the regulatory systems of several ECF σ factors, 
including E. coli σE and FecI, B. sutilis σW, P. aeruginosa σAlgT/U, and S. coelicolor σR, 
have suggested a few common features of these systems (47, 116) (Figure 1.6). An 
ECF σ factor operon often encodes the σ factor and a corresponding anti-σ factor. In 
the absence of a stimulus, the anti-σ factor sequesters and inactivates its cognate ECF 
σ factor through protein-protein interactions. In the presence of an external signal, the 
anti-σ factor is inactivated by proteolysis, conformational change, or another 
mechanism, and releases the ECF σ factor. The σ factor is then free to bind to RNAP 
core and direct transcription of its own operon (autoregulation) and other target genes. 
However, there are some exceptions. For example, σZ in B. subtilis is not known to be 
regulated by an anti-σ factor, or to autoregulate its own expression (4). σE in S. 
coelicolor is activated by a two component system CseCB (56). In Mycobacterium 
tuberculosis, σJ and σI are regulated through a transcriptional cascade, where the 
activation of σJ can induce the expression of σI (55).  
 
1.4 ECF σ factors and cell envelope stress response 
B. subtilis encodes 7 ECF σ factors, namely σM, σW, σX, σY, σV, σZ and σYlaC (Figure 
1.6). The inducing conditions and physiological roles of four of the σ factors (σM, σW, 
σX, and σV) have been well characterized (35, 45, 47, 60). They respond cell-envelope  
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disrupting compounds, and activate the expression of large sets of genes. Studies on 
the other three σ factors (σY, σZ and YlaC) are ongoing. σY is weakly induced by 
nitrogen starvation (129). It is only know to directly regulate its own operon, and one 
gene ybgB (encoding a membrane protein with unknown function). YlaC is induced in 
response to hydrogen peroxide (108). The inducing conditions for σZ remain unknown.  
  
1.4.1. The best defense is a good offense: ECF σ factors control antibiotic production 
As described above, most antibiotics are secondary metabolites of soil microorganisms 
(i.e. they are produced through non-essential, secondary pathways that are dispensable 
in many growth conditions) (106). Under nutrient limiting or other stressful growth 
conditions, expression of these metabolites may provide survival advantages, ranging 
from inhibiting competitors to controlling cell growth and differentiation (104, 106) 
(discussed in section 1.2.3).  
Strains of B. subtilis can produce over two dozen antibiotics (bacteriocins) 
collectively, most of which are strain specific (1, 118). The common lab strain 168 is 
capable of producing seven bacteriocins, including five ribosomally synthesized 
peptide antibiotics: sublancin (91), subtilosin A (5, 148), the SdpC sporulation delay 
protein (44), the SkfA killing factor (3, 44), and the TasA protein (121), and two non-
ribosomally synthesized antibiotics: the phospholipid bacilysocin (126), and the 
dipeptide bacilysin (59, 65). B. subtilis 168 also possesses synthase genes for 
surfactants (surfactin and fengycin) and polyketides, but they are not produced due to 
a frame-shift mutation in the gene encoding the phosphopantetheine transferase Sfp. 
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Sfp is required to activate the surfactin and fengycin synthetase, as well as polyketide 
synthase (118). This is likely due to mutations accumulated from the mutagenesis 
work with X-rays in the mid-1940s and a long history of laboratory cultivation (17, 
147). As a result of this history, numerous genetic and phenotypic differences exist 
between domestic lab strains.  
The expression of bacteriocins is controlled by multiple regulatory pathways. 
The transcription of the sunA operon (encoding sublancin) is repressed by a 
pleiotropic transcriptional regulator AbrB. This repression is relieved by 
phosphorylated Spo0A which inhibits abrB transcription upon entering stationary 
phase (122). In Chapter 2, we present evidence that ECF σ factors σX (mainly) and σM 
(to a lesser extent) can activate the expression of a third transcriptional regulator and 
an AbrB homolog, Abh. Abh competes with AbrB for binding at the sunA promoter, 
resulting in increased sublancin production (78, 123). The activation of abh 
transcription through σX ultimately increases the expression of the yqxM-sipW-tasA 
operon (88). TasA is not only a bacteriocin that is capable of inhibiting both Gram-
positive and negative bacteria (121), but also a major protein component of biofilm 
matrix (12). TasA proteins form amyloid fibers that are essential for the integrity of 
the matrix (103). These fibers are anchored to the cell wall by YqxM (TapA), encoded 
by the first gene of the operon (105).  
σY was recently reported to be required for maintaining the SPβ prophage that 
harbors the sunA operon in a B. subtilis 168 derivative strain called JH642 (82), 
although we did not observe the loss of SPβ in our 168 strain when sigY is deleted. 
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Finally, σM is known to regulate the expression of a phospholipase (YtpA) that is 
required for bacilysocin synthesis (35, 126).  
1.4.2 The defense: ECF σ factor contributes to antibiotic resistance. 
ECF σ factors and their regulons can also directly defend against antibiotic stress 
through the enzymatic inactivation of antibiotics or modification of the drug targets. 
The individual regulons of σM, σW, σX, and σV, although partially overlapped, 
contribute uniquely to these ends (45, 47).  
σX was one of the first ECF σ factors to be studied in detail. A sigX mutant is 
prone to cell lysis and sensitive to nisin and other CAMPs (20) The σX regulon 
includes two key operons (dltABCDE and pssA-ybfM-psd). The Dlt proteins 
incorporate positively charged D-alanine into TA (95). PssA and Psd catalyze the 
synthesis of the neutral cytoplasmic membrane lipid phosphatidylethanolamine. The 
incorporation of both positively charged TA and neutral lipids reduces the net negative 
charge of the membrane, thereby contributing to CAMP resistance and the prevention 
of cellular autolysis (20). 
 σW is perhaps the best studied ECF σ factor in B. subtilis. It is induced by 
several cell wall-acting antibiotics including fosfomycin, bacitracin, vancomycin, 
cephalosporin C, sublancin, and the toxic peptide SdpC (18, 22, 96). It is also induced 
by detergents (e.g. Triton-X-114, SDS) (22) and alkali stress (142). The activation of 
σW stimulates “antibiosis” regulons that provide resistance to some inducers such as 
fosfomycin, sublancin and SdpC (47). Fosfomycin is an inhibitor of MurA, the 
enzyme that catalyzes the first committed step in PG synthesis (63) (Figure 1.2). σW 
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activates the expression of fosB, a bacillithiol-S-transferase that enzymatically 
inactivates fosfomycin (19, 40). Together fosmycin and σW form an efficient feed-
back loop, where the presence of fosfomycin induces σW, and σW mediates the 
detoxification of fosfomycin. Both sublancin and SdpC are bacteriocins produced by B. 
subtilis, and their immunities are provided by the immunity gene products of sunI (34) 
and sdpI (36), respectively. In strains lacking sunI or sdpI, the role of σW in resistance 
becomes apparent due to its regulation at three operons: the yqeZ yqfAB operon 
(sublancin resistance), and the yknWXYZ and yfhLM operons (SdpC resistance) (18). 
The functions of these operons are unknown, but yknWXYZ encodes a putative ABC 
transporter and yfhL encodes an SdpI paralog. YqeZ is a putative membrane-bound 
protease, and YqfAB are putative NefD-like flotillins. In addition, σW also contributes 
to the resistance to detergents and antimicrobial compounds produced by other bacilli 
(e.g. Bacillus amyloliquefaciens and Bacillus atrophaeus). This is in part due to the 
activity of a σW-dependent promoter located within the gene fabHa. Transcription 
initiated from this promoter reduces expression of fabHa and increases the 
transcription of downstream gene fabF, resulting in modulation in membrane fatty 
acid composition and a reduction in membrane fluidity (67).  
M is induced by bacitracin, vancomycin, moenomycin, and rhamnolipid (a 
biosurfactant produced by P. aeruginosa). The activation of σM confers resistance to 
bacitracin, moenomycin and rhamnolipid (35, 80, 127, 139). Bacitracin inhibits PG 
synthesis by binding to undecaprenyl pyrophosphate (UPP) and thereby preventing its 
recycling to the monophosphate form (120) (Figure 1.2). σM contributes to bacitracin 
resistance by upregulating the expression of bcrC (21, 81). BcrC is an UPP 
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phosphatase and is able to compete with bacitracin for the UPP substrate (9). The bcrC 
promoter is also recognized by X and σI (21, 132). How σM contributes to 
moenomycin and rhamnolipid resistance is less clear, and the genes responsible have 
not yet been identified. However, ECF  factors such as σM have the potential to 
modulate the structure of the entire cell envelope and thereby contribute to antibiotic 
resistance. Components of the lateral cell wall synthesis complex (MreBCD, RodA, 
PBP1), PG biosynthetic enzymes (MurB, MurF, Ddl), and divisome components 
(MinCD, DivIB) all harbor σM promoters (Figure 1.3). In addition, σM also regulates 
the transcriptional regulators Spx and Abh, which are involved in resistance to the β-
lactam drug cefuroxime (Chapter 4). 
 σV is induced by and provides resistance to lysozyme (45, 51). Lysozyme is a 
muramidase that cleaves the β-1,4-glycosidic bond between MurNAc and GlcNAc 
(Figure 1.2). In addition, this positively charged enzyme also functions as a CAMP 
(50, 136). σV contributes to lysozyme resistance by regulating expression of the 
dltABCDE operon and gene oatA, the latter which is transcribed as part as the sigV 
operon (sigV-rsiV-oatA-yrhK). OatA is a MurNAc specific O-acetyltransferase and O-
acetylation of MurNAc reduces the ability of lysozyme binding to its substrate (8). 
The D-alanylation at TA through the activity of dlt operons helps to repel lysozyme 
from cell envelope. In addition, PbpX, a low molecular weight PBP and a member of 
the σX and σV regulons, may also contribute to lysozyme resistance (51).  
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1.4.3 The overlapping regulation of ECF σ factors 
One major challenge in studying the regulation by ECF σ factors is the significant 
overlap in their regulons. Of the 60 genes regulated by σW, ~20 can be recognized by 
σX, σM, or σV. Similarly, about 30 out of the ~60 gene σM regulon, about 20 of the ~30 
gene comprising the σX regulon, and almost all of the ~30 genes in the σV regulon can 
also be activated by a subset of, or all of the other three σ factors. This large degree of 
regulatory redundancy is mainly due to the fact that these ECF σ factors recognize a 
highly conserved “AAC” motif in the −35 region and a “CGT” motif in the −10 region 
of their promoters (Figure 1.7) (45, 80, 116) . 
 Despite this pronounced redundancy, some promoters are exclusively 
recognized by a single ECF σ factor. Even for promoters that can be activated by 
multiple σ factors, there appear to be a preference for certain σ factors. For example, 
the transcription of abh is primarily driven by σX, and only weakly by σM (Chapter 2, 
(78)). The expression of bcrC largely depends on σM, and less on σX (21). The 
mechanism for this promoter selectivity is not yet clear, but it is likely derived from 
the interaction between promoter DNA nucleotides and amino acids of the σ proteins. 
One example is σW and σX and their interactions with the -10 element (98). σX 
recognizes the CGAC motif of -10 element, while σW recognizes CGTA. Both σ 
factors can recognize CGTC at this site (Figure 1.7). Altering the motifs in the -10 
element can switch the promoter preference for either σX or σW. Similarly, promoters 
recognized by σMWXV appear to contain multiple T’s downstream of the -35 element, 
while this feature is less prominent in promoters recognized by only σMWX (Figure 1.7).  
 Figure 1.7. 
Each consen
single or 
(http://webl
represented 
80). 
Promoter se
sus was ge
multiple E
ogo.berkeley
by the heig
quence con
nerated with
CF σ fa
.edu/logo.c
ht of nucleo
 
27 
sensuses rec
 promoter s
ctors (as 
gi). The d
tide symbo
ognized by 
equences th
indicated) 
egree of 
ls at each p
ECF σ facto
at are recog
at the W
sequence c
osition. Ada
rs in B. sub
nized by ei
eblogo ser
onservation
pted from 
 
tilis. 
ther 
ver 
 is 
(45, 
 28 
It is possible that these T’s may facilitate the interaction between σV and the promoter 
DNA (45). 
The regulatory redundancy of ECF σ factors complicates the studies on 
individual σ factors and their functions: the effect of a single ECF σ factor deletion is 
often masked by the expression of others. As a result, some phenotypes are only 
detectable when two or more ECF σ factors are mutated. For example, a triple mutant 
of sigMWX (strain ΔMWX) displays additional phenotypes not found in any of the 
single mutants. These phenotypes include increased susceptibility to several detergents 
and to cell wall-acting antibiotics ampicillin, D-cycloserine, and polymyxin B (80). 
When all 7 ECF σ factors were eliminated (strain Δ7ECF), additional phenotypes and 
transcriptional changes were also observed compared those in strain ΔMWX (Chapter 
3). The overlapping regulation of ECF σ factors suggests a very intricate regulatory 
network, which could serve as a means to guarantee cell envelope integrity in a 
chemically-diverse environment. 
 
1.5 Content of the dissertation 
This dissertation focuses on the regulatory role of ECF σ factors in antibiotic 
production and resistance. In order to study the function of an individual ECF σ factor 
in an overlapping regulatory network, the major strategy employed in this work is to 
start with a multiple ECF σ mutant strain with a detectable phenotype, deduce the 
dominant σ factor by a process of elimination, and investigate the pertinent pathways 
that are regulated by the σ factor. 
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In chapter 2, research began with the observation that strain ΔMWX lost the 
ability to inhibit the growth of other bacilli strains as compared to the wild type strain. 
We showed that two ECF σ factors, σX and σM, are the relevant σ factors by testing all 
the possible combinations of single, double, and triple mutants of sigMWX. σX (mainly) 
and σM (to a less extent) regulate the expression of Abh, which directly activates the 
transcription of the sunA operon for sublancin production. Sublancin can inhibit the 
growth of nonlysogenic strains of B. subtilis and its close relatives Bacillus pumilus, 
Bacillus licheniformis, and B. amyloliquefaciens, as well as other Gram-positive 
bacteria, such as S. aureus. Therefore, it may provide competitive advantage in a 
diverse microbial environment. 
Chapter 3 deals with the overlapping regulation of ECF σ factors. We acquired 
a strain harboring all 7 ECF σ null mutations (Δ7ECF) through collaboration with Kei 
Asai and Yoshito Sadaie (Saitama University, Japan). We compared the 
transcriptomic and phenotypic signatures associated with strains of Δ7ECF and 
ΔMWX. This comparison also allowed us to distinguish the functional contributions 
of the well-studied σ factors (sigMWX), and the lesser understood σ factors (sigVYZ 
ylaC). We found approximately 80 genes that at least partially depend on ECF σ factor 
for expression, most of which are regulated by σM, σW or σX. We also found new 
antibiotic sensitivity phenotypes associated with ECF σ factors, including two β-
lactam drugs called aztreonam and cefuroxime. In addition, strain Δ7ECF showed 
greater reduction in biofilm formation than strain ΔMWX, suggesting a possible role 
of σYVZYlaC in biofilm formation. 
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Chapter 4 considers the regulatory role of ECF σ factors in mediating 
cefuroxime resistance. σM is the major determinant and σX plays a secondary role. 
Using a Tn7 random mutagenesis-based analysis, we found that these two σ factors 
regulate three pathways involving Spx, Abh, and DisA. We propose that Spx 
contributes to drug resistance by antagonizing the ROS stress imposed by cefuroxime. 
Abh indirectly represses the expression of autolysin genes and thus inhibits cell lysis. 
DisA is a cyclic-di-AMP (c-di-AMP) synthase. c-di-AMP is essential for cell growth, 
and is involved in maintaining PG homeostasis.  
In summary, the bacterial cell envelope is a vital cellular structure and a prime 
target for antibiotics. In B. subtilis, cell wall targeting antibiotics often induce the 
expression and activity of ECF σ factors, which activate a complex stress response. 
This ECF σ mediated response not only provides protection from antibiotics but also 
provides competitive advantages by regulating antibiotic production which can inhibit 
competitors in the soil environment.   
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CHAPTER 2 
EXTRACYTOPLASMIC FUNCTION SIGMA FACTORS WITH OVERLAPPING 
PROMOTER SPECIFICITY REGULATE SUBLANCIN PRODUCTION IN 
BACILLUS SUBTILIS 
 
Bacillus subtilis harbors seven extracytoplasmic function (ECF) σ factors. At least 
three ECF σ factors (M, W and X) are induced by, and provide resistance to, 
antibiotics and other agents eliciting cell envelope stress. Here, we report that ECF σ 
factors also contribute to antibiotic production. B. subtilis 168 strains that are 
lysogenic for the SPß bacteriophage produce sublancin which inhibits the growth of 
other, non-lysogenic strains. Genetic studies demonstrate that synthesis of sublancin is 
largely dependent on X with a smaller contribution from M. A sigM sigX double 
mutant is unable to produce sublancin. This defect is primarily due to the fact that the 
sublancin biosynthesis is positively activated by the transition state regulator and 
AbrB paralog Abh, which counteracts transcriptional repression of the sublancin 
biosynthesis operon by AbrB. Ectopic expression of abh bypasses the requirement for 
M or X in sublancin synthesis, as does an abrB mutation. In addition to their major 
role in regulating sublancin expression by activating abh transcription, X and M also 
have a second role as positive regulators of sublancin expression that is independent of 
AbrB and Abh. Since sublancin resistance in non-lysogens is largely dependent on W, 
ECF σ factors control both sublancin production and resistance. 
 The results of this study were published in Luo Y and Helmann JD. Journal of 
Bacteriology. 2009 Aug;191(15):4951-8.  
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2.1 Introduction 
Bacillus subtilis, a ubiquitous soil bacterium, inhabits a fiercely competitive niche and 
devotes a large fraction of its genome to genes implicated in the synthesis of, and 
resistance to, antibacterial compounds. Regulation of antibiotic resistance functions is 
frequently mediated by extracytoplasmic function (ECF) σ factors which, as a class, 
control functions related to cell envelope and transport. 
  B subtilis harbors seven known ECF σ factors: M, W, X, Y, Z,V and YlaC 
(17). Of these, the M, W and X regulons are the best characterized. These three  
factors control overlapping sets of genes that are important for resistance against a 
variety of cell envelope-active compounds and antibiotics. In several cases, resistance 
genes are controlled predominantly by a single ECF σ factor. For example, σW 
controls genes that confer resistance to the peptidoglycan synthesis inhibitor 
fosfomycin (3), the toxic peptide SdpC, and the lantibiotic sublancin (2). The σM 
regulon includes a large number of operons implicated in cell wall synthesis and the 
corresponding sigM mutant is sensitive to several cell wall antibiotics including 
bacitracin, vancomycin and moenomycin. The σX regulon includes operons that 
modulate the net charge of both the cell membrane and cell wall and a sigX null 
mutant displays increased sensitivity to nisin and other cationic antimicrobial peptides 
(4, 5). In other cases, resistance to antimicrobial compounds appears to be dependent 
on gene(s) that are potentially expressed by more than one ECF σ factor. As a result, 
strains carrying multiple deletions in sigM, sigW and sigX show sensitivities to 
additional antibiotics such as D-cycloserine and some β-lactam antibiotics (21).  
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 B.subtilis strains are known to produce more than two dozen antibiotics (31). 
In several cases, antibiotic biosynthesis and associated immunity functions are 
encoded on genomic islands or phage and are potentially transferred between closely 
related species by either transduction or natural competence. Sublancin 168 (hereafter 
called sublancin) is one of the bactericidal antibiotics produced by the reference strain, 
B.subtilis 168. Sublancin is classified as an unusual lantibiotic, with a β-
methyllanthionine bridge and two disulfide bridges (26). Sublancin is extremely 
stable, and is active against gram-positive bacteria, including strains of B. cereus, 
Staphylococcus aureus, and Streptococcus pyogenes. It inhibits both the outgrowth of 
endospores and vegetative cell growth. The mode of action has been speculated to 
involve pore formation in the cytoplasmic membrane. Kouwen et al. have recently 
found that a mechanosensitive channel of conductance MscL is required for sublancin 
susceptibility, but the precise mechanism remains unknown (20).  
 The sublancin operon is located in the prophage SP genome. This 4.5kb 
segment contains 5 genes: sunA, sunT, bdbA, yolJ, and bdbB (Figure 2.1A). All, 
except bdbA, are essential for sublancin production (8, 9). The structural gene sunA 
encodes presublancin, which is a 56-residue polypeptide possessing a 19-residue 
leader segment (26). sunT is located immediately after the sunA gene and encodes 
ABC-type transporter containing a proteolytic domain thought to cleave the leader 
peptide of sublancin during secretion across the membrane (9, 24). BdbB and BdbA 
comprise a thiol-disulfide oxidoreductase involved in the post-translational formation 
of disulfide bonds in sublancin (9). YolJ (SunS) contains a CxxS motif and it is also 
involved in the modification of sublancin (8, 33).   
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 In this study, we show that the synthesis of sublancin requires the activity of 
either of two ECF σ factors, M and X. Genetic analyses establish that the influence 
of σM and σX results from their ability to activate transcription of abh which encodes a 
paralog of the pleiotropic transition state regulator protein AbrB. Both σM and σX can 
recognize an ECF σ factor-dependent promoter element preceding the abh gene and 
expression of abh from a heterologous promoter bypasses the requirement for either of 
these ECF σ factors. The function of Abh in activation of the sunA operon is to 
prevent repression by AbrB: sunA activity is constitutive in an abrB abh double 
mutant strain. Together with previous results, these findings establish that ECF σ 
factors control both the production of, and resistance to, antimicrobial compounds.  
 
2.2 Material and Methods 
Strains, plasmids and growth conditions. All B. subtilis strains, plasmids and 
oligonucleotides (oligos) used in this study are listed in Table 2.1. Bacteria were 
grown in liquid Luria–Bertani (LB) medium at 37°C with vigorous shaking, or on 
solid LB medium containing 1.5% Bacto Agar (Difco) with appropriate selection. 
Plasmids were amplified in Escherichia coli DH5α before transformed into B. subtilis 
strains. Ampicillin (amp, 100 μg ml−1) was used to select E.coli strains harboring 
desired plasmids. For B. subtilis, antibiotics used for selection were as follows: 
spectinomycin (spc, 100 μg ml−1), kanamycin (kan, 10 μg ml−1), tetracycline (tet, 5 
μg ml−1), chloramphenicol (cat, 5 μg ml−1), and macrolide-lincosoamide-streptogramin 
B (mls, contains 1 μg ml−1 erythromycin and 25 μg ml−1 lincomycin). 
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Table 2.1. Strains, plasmids and oligos used in this study. 
 Strains, 
Plasmids, 
or Oligos 
Genotype, description Construction, reference, or oligo sequence 
 
B.subtilis strains 
 
168 trpC2 Y.Sadaie (Saitama University, 
Japan) 
CU1065 trpC2 attSP Lab strain 
HB 5331 CU1065 yqeZyqfAB::kan (2) 
HB10016 168 sigM::tet LFH-PCR168 
HB10103 168 sigX::kan LFH-PCR168 
HB6164 CU1065 sunA::kan (2) 
HB10111 168 sunA::kan HB6164 chrDNA168 
HB10113 168 sigM::tet sigX::kan HB10103 chrDNA  HB10016 
HB10131 168 abh::spc LFH-PCR168 
HB10139 168 abrB::tet LFH-PCR168 
HB10146 168 abh::spc abrB::tet HB10139 chrDNA  HB10131 
HB0020 CU1065 sigW::mls (3) 
HB10102 168 sigW::mls HB0020 chrDNA 168 
HB10107 168 sigM::tet sigX::kan sigW::mls HB10102 chrDNA  HB10113 
HB0911 CU1065 sigV::cat (21) 
HB10101 168 sigV::cat HB0911 chrDNA 168 
HB0009 CU1065 sigY::mls (7) 
HB10108 168 sigY::mls HB0009 chrDNA 168 
HB0032 CU10665 sigZ::kan (6) 
HB10109 168 sigZ::kan HB0032 chrDNA 168 
HB0029 CU1065 ylaC::kan (6) 
HB10110 168 ylaC::kan HB0029 chrDNA 168 
HB10182 168 sunA::kan abh::spc HB10111 chrDNA HB10131 
HB10143 168 sigM::tet sigX::kan abh::spc  
amyE::PsunA-lacZ (cat) 
HB10131 chrDNA, pYL18 
HB10113 
HB10155 168 sigM::kan sigX::spc abrB::tet 
amyE::PsunA-lacZ(cat) 
HB10139 chrDNA, pYL18 
HB10113 
HB10123 168 lacA::PxylA-abh(mls)  pYL19 168 
HB10124 168 sigX::kan lacA::PxylA-abh(mls)  HB10103 chrDNA HB10123 
HB10128 168 sigM::tet lacA::PxylA-abh(mls) 
amyE::PsunA-lacZ(cat) 
HB10016 chrDNA, pYL18 
HB10123 
HB10137 168 sigM::tet sigX::kan  lacA::PxylA-
abh(mls) amyE::PsunA-lacZ(cat) 
HB10103 chrDNA, pYL18 
HB10123 
SWV121 trpC2 pheA1 amyE::Pabh-lacZ(cat) M. Strauch (University of Maryland) 
HB10147 168 amyE::Pabh-lacZ(cat) SWV121 chrDNA  168 
HB10148 168 sigM::tet amyE::Pabh-lacZ(cat) HB10147 chrDNA  HB10016 
HB10149 168 sigX::kan amyE::Pabh-lacZ(cat) HB10147 chrDNA  HB10103 
HB10150 168 sigM::tet, sigX::kan  amyE:: Pabh–
lacZ(cat) 
HB10147 chrDNA  HB10113 
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Table 2.1 (continued) 
 
Plasmids 
 
    
pYL18 pDG1661-PsunA-lacZ (cat) This work 
pYL19 pAX01- PxylA-abh (mls) This work 
 
Oligos 
 
    
4195 sunA-for ATGGAAAAGCTATTTAAAGAAG 
4196 sunA-rev TCTGCAGAATTGACGATAGT 
4368 23S-RT-F AAAGGCACAAGGGAGCTTGACTG
CGAGA 
4369 23S-RT-R ATGAGCCGACATCGAGGTGCCAA
ACCT 
3314 AAP GGCCACGCGTCGACTAGTACGGGI
IGGGIIGGGIIG 
4370 abh-rev-GSP1 GGCTTGAATTTCTTCGA 
4371 abh-rev-GSP2 ACGCCATGAGGTTTGTACTT 
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Genetic techniques. Gene deletions were generated using long-flanking-homology 
polymerase chain reaction (LFH-PCR) as described (2, 22) with selection for the 
appropriate antibiotic resistance cassette. Chromosomal DNA transformations were 
performed as described (16). 
Spot-on-lawn assays. Spot-on-lawn assays were performed as previously described 
(2). Briefly, lawn cells were grown to OD600 of 0.4 in LB, mixed 1:50 (culture: 
medium) with 2ml melted 0.7% or 1.5% LB agar, and poured into wells of an 8-well 
rectangular multidish (26mmx33mm, Nunc). Plates were dried for 30min in a laminar 
flow hood, and 2μl of the producer strain (OD600 of 0.6) was spotted in the center of 
the well. Plates were incubated at 37C overnight (18h) before observation. Spot-on-
lawn assays of each strain were performed in biological triplicates, and repeated at 
least three times. Several mutant strains harbor a reporter fusion amyE::PsunA-
lacZ(cat). The presence of this reporter fusion did not influence the results of the spot-
on-lawn assays.  
-galactosidase assays. Test strains carrying either an abh promoter-lacZ (Pabh-lacZ) 
fusion were grown overnight in LB medium containing appropriate antibiotics, and 
diluted 1:100 into 5ml LB medium. The cultures were incubated at 37C with 
vigorous aeration, and sampled from logarithmic, transition, and stationary growth 
phases. -galactosidase assays of each strain were performed in biological triplicate as 
described by Miller (25), and repeated at least three times. Data are reported as the 
mean and standard deviation. 
RNA isolation, northern blotting, and slot blotting. Total RNA was extracted from 
2 ml of cells grown to an OD600 of 0.4 (mid-log phase) using the RNeasy kit 
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(QIAGEN) according to the manufacturer's protocol. The RNA was quantified using 
Nanodrop spectrophotometer (NanoDrop Technologies) and visualized by agarose gel 
electrophoresis. Two DNA probes, sunA and 23rRNA were constructed by PCR with 
the primer pairs sunA-for (4195) and sunA-rev (4196), 23S-RT-F (4368) and 23S-RT-
R (4369), respectively (Table 2.1). The probes were purified using the QIAGEN PCR 
purification kit and labeled with [-32P] dATP (3,000 Ci/mmol, 10 mCi/μl; New 
England Nuclear) and T4 polynucleotide kinase (New England Biolabs). 
Unincorporated [-32P] dATP was removed using a QIAGEN PCR purification kit. 
Northern blotting analysis was carried out by using the NorthernMax formaldehyde-
based system (Ambion) following the manufacturer's instruction with 10 μg of total 
RNA and Zeta-Probe blotting membrane (Bio-Rad) in a downward transfer setup. The 
slot blotting was performed as described (29), where total RNA was transferred to 
Zeta-Probe blotting membrane using vacuum. The hybridization and washing steps for 
both Northern blot and slot blotting were performed with the NorthernMax 
hybridization kit according to the manufacturer’s instruction. The blots were then 
wrapped in plastic wrap, exposed for 12h to a phosphor screen (Molecular Dynamics), 
and scanned using a Storm 840 PhosphorImager (Molecular Dynamics). The resulting 
images were analyzed with ImageQuant software (Molecular Dynamics). 
5' rapid amplification of cDNA ends (5’ RACE). The transcriptional start site of abh 
was determined using 5' RACE. Two g of total RNA from mid-log phase culture 
were reversed transcribed to cDNA using TaqMan reverse transcription reagents 
(Roche) and oligo abh-rev-GSP1 (4370) as primer. The 3’ end of cDNA was tailed 
with poly dCTP using terminal deoxynucleotidyl transferase (New England Biolabs). 
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The tailed cDNA were then amplified by PCR with primers AAP (3314) and abh-rev-
GSP2 (4371). The PCR products were sequenced with Sanger sequencing technology.  
 
2.3 Results and Discussion 
ECF σ factors regulate antibiotic production. Previous studies have established that 
ECF σ factors, and in particular σW, plays a major role in the antibiotic-inducible 
expression of genes that provide resistance to bacteriocins and antibacterial peptides 
produced by other soil microorganisms including other Bacillus spp. (2). To determine 
whether ECF σ factors also contribute to antibiotic production, we tested the ability of 
B. subtilis strain 168 to inhibit the growth of other Bacillus spp. using a spot-on-lawn 
assay. In an initial screen, wild type (WT) strain 168 and its isogenic triple mutant 
lacking σM, σW, and σX (sigMWX, HB10107) were used as spots, and 23 strains of 
Bacillus spp. (listed in Table S2.1) were used as lawn cells. Sixteen of the 23 strains 
showed less susceptibility to the triple σ factor mutant than to strain 168, while the 
other seven strains were similarly susceptible to both strains. Three representative 
stains that have differential susceptibility are shown in Figure 2.1B. In all cases, the 
inhibition zone sizes from sigMWX spots were significantly reduced compared to 
those from strain 168. This result indicates that X, M, or W, individually or in 
combination can regulate antimicrobial activity against other Bacillus spp. Notably, 
this antimicrobial activity was not observed using the 168 derivative strain CU1065 as 
the spotted strain (data not shown). Strain 168 differs from strain CU1065 in that it 
carries prophage SP, which encodes the lantibiotic sublancin 168 (26). To test 
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whether the killing effect of 168 cells was due to sublancin, a derivative of 168 
lacking sunA (sunA, HB10111) was spotted on lawns of the same 23 Bacillus spp. 
Deletion of sunA abolished the killing effect noted for all 16 strains that showed a 
differential susceptibility to 168 versus the sigMWX strain (Figure 2.1B). This 
suggests that the product of the sunA gene (sublancin) is a major antibiotic active 
against other Bacillus spp. and is regulated either directly or indirectly by X, M, or 
W. 
X or M is essential for sublancin production. In order to identify which ECF  
factor(s) regulate sublancin production, more comprehensive spot-on-lawn assays 
were conducted using single, double, and triple ECF  mutants as spots. The sublancin 
sensitive strain, strain CU1065, was used as the lawn strain. Since CU1065 lacks the 
SP prophage, it lacks both the ability to synthesize sublancin and the SP encoded 
immunity gene sunI (10), rendering it susceptible to killing by sublancin. As shown in 
Figure 2.2A (upper panel), we tested seven single ECF  deletion mutant spots and 
only sigX (HB10103) and sigM (HB10016) strains showed reduced inhibition zone 
sizes compared to that from the WT spot. Judging from zone diameters, the sigX 
strain impaired cell killing to a greater degree than did the sigM strain. Deletions in 
sigX and sigM were additive as a sigMX double deletion strain (HB10113) 
completely abolished the killing effect. This result indicates that X and M are the 
ECF  factors that regulate sublancin production. 
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In order to confirm that sigM and sigX are strictly required for sublancin 
production, the sigMX strain was spotted on a lawn of strain HB5331, a sublancin 
hypersensitive strain that harbors a yqeZ-yqfAB deletion in a CU1065 background 
(Figure 2.2A, lower panel). The yqeZ-yqfAB operon is expressed from a σW-dependent 
promoter and confers a modest level of resistance to sublancin in strains lacking SP 
(2). Even with this hypersensitive strain, no sublancin production (cell killing) was 
detected from a sigMX double deletion spot (Figure 2.2A, lower panel), suggesting 
that in the absence of both of these σ factors, sublancin expression is effectively 
abolished.  
Abh counteracts AbrB repression in sublancin synthesis. The region upstream of 
sunA harbors a consensus A promoter sequence, but no apparent recognition 
sequences for either X or M (Figure 2.1A). This observation suggests an indirect 
regulatory role for X and M in activating sunA transcription. We therefore examined 
two additional regulators of sublancin transcription, Abh and AbrB, which bind 
overlapping sequences in the sunA promoter region. It has been proposed that AbrB is 
a repressor and Abh is an activator for sunA, but how they cooperate or compete to 
influence the overall regulation of sunA transcription remains unclear (32). In previous 
studies, an abh mutant was found to have an ~2-fold decrease in the level of 
expression from a sunA-lacZ reporter fusion (32) and we previously demonstrated that 
X recognizes a promoter upstream of the abh gene (18). Thus, it seemed plausible 
that Abh might provide the link between ECF  factor activity and activation of 
sublancin expression. 
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 In our spot-on-lawn assays, when a strain carrying a deletion of abh (abh, 
HB10131) was spotted onto the highly sensitive indicator strain HB5331, the 
inhibition zone was significantly reduced comparing to that from strain 168 (Fig. 2A, 
lower panel, and Fig. 2B), which confirms a positive role for Abh in sublancin 
production. However, when strains abrB (HB10139) and abh abrB (HB10146) 
were spotted onto the same lawn, the zones of inhibition were comparable to the wild-
type strain 168. These results suggest that the role of Abh is to counteract repression 
mediated by AbrB: if AbrB repression is absent, Abh is not needed. This result 
contradicts the previous suggestion that Abh might function as a direct activator of 
sublancin expression since an abh abrB double mutant apparently failed to make an 
antimicrobial compound (presumed to be sublancin) as detected using B. coagulens as 
an indicator strain (32). 
 If the regulation of sublancin production by X or M is solely through Abh, 
one would predict that a abh mutant would fail to make any detectable sublancin as 
also noted for the sigMX double mutant in this bioassay. However, there is clearly 
residual antibacterial activity in the abh strain (Figure 2.2). We first considered the 
possibility that the abh deletion might derepress synthesis of one or more antibiotics 
that are negatively regulated by Abh (32). However, the residual antibiotic activity in 
the Δabh strain was eliminated in a Δabh sunA double mutant (HB10182), indicating 
that this activity was due to sublancin synthesis (Figure 2.2). This raised the 
possibility that, in addition to their effects on Abh production, X or M may have a 
second pathway by which they activate sublancin synthesis. Consistent with this 
notion, deletion of sigM and sigX not only removes the residual activity detected in an 
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abh deletion strain, it also reduces the level of sublancin activity in an abrB deletion 
strain (Figure 2.2A, lower panel, and 2.2B). Together, these results suggest that X or 
M likely regulate sublancin production both by activation of Abh (which counteracts 
AbrB repression) and independent from Abh or AbrB.  
X or M is required for transcription of sunA. To test whether the observed effects 
on sublancin production were due to regulation of sunA transcription, we measured 
mRNA levels using Northern blotting (Figure S2.1) and RNA slot blotting (Figure 
2.3). The sublancin operon was previously found to be transcribed as two separate 
transcripts: sunA (0.2 kb) and sunT-bdbA-yolJ-bdbB (4.3 kb) (30). However, our 
Northern analysis detected a single major transcript of approximately 2~2.5kb using 
sunA as a probe (Figure S2.1). Our results suggest that sunA is, at least, co-transcribed 
with sunT. The downstream genes bdbA, yolJ and bdbB may also be co-transcribed 
with sunAT, since no gaps exist between sunT-bdbA, bdbA-yolJ, and yolJ-bdbB. This 
expected transcript of 4.5 kb was, however, not detected, which is possibly due to 
RNA processing. Interestingly, sunA gene itself is one of the most stable mRNAs in B. 
subtilis although no specific secondary structure related to mRNA stability was noted 
at its 5’end (15). We noted the presence of a potential hairpin in the 60 bp space 
between sunA and sunT (ΔG=-14.5 kcal/mol as determined using Mfold; (23, 34) 
(Figure 2.1A). It is possible that this 3’-end secondary structure protects sunA mRNA 
from degradation. 
As expected based on the phenotype assays, sunAT mRNA levels were 
significantly reduced in the sigX, sigMX and abh mutant strains (Figures. 2.3 and 
S2.1). Indeed, even the sigX single mutant greatly reduced sunAT mRNA levels, 
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X and M dependent transcription of Abh activates sunAT transcription. 
Previous studies have shown that X and M can both contribute to the expression of 
abh (11, 18) and an ECF  type consensus sequence is found upstream of abh (see 
Figure 2.5A). Our genetic analyses also suggested that the primary effects of X and/or 
M in activating sublancin synthesis is dependent on Abh which then indirectly 
activates sunA. In order to test this model, a xylose-inducible abh allele was 
introduced into the lacA locus in the background of 168, sigM, sigX and sigMX 
strains (strains HB10123, HB10124, HB10128 and HB10137, respectively). Induction 
of abh expression restored sublancin production to each of these single and double 
mutants (Figure 2.4), effectively bypassing the requirement for ECF  factors. Note 
that the sizes of the inhibition zones in this assay (Figure 2.4) are somewhat reduced 
relative to that seen in comparable assays (Figure 2.2A, upper panel). This might be 
due to the presence of xylose in this medium (to induce abh transcription), as it has 
been reported that xylose can modify sublancin and interfere with its bacteriocin 
activity (9). Nevertheless, it is clear that ectopic induction of Abh restores sublancin 
production in the sigMX strain.  
The regulation of abh transcription by X and M was further confirmed using 
β-galactosidase assays with a transcriptional reporter fusion (Pabh-lacZ). The Pabh-lacZ 
construct was introduced at amyE in the 168, single, and double mutants of sigM and 
sigX (strains HB10147, HB10148, HB10149 and HB10150). Pabh activity was slightly 
reduced in the sigM mutant, and strongly reduced in the sigX mutant (Figure 2.5B). 
No -galactosidase activity was detected in the sigMX double mutant.  
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This result suggests that the activity of Pabh requires X or M and that X is the major 
regulator under these growth conditions. These results are entirely consistent with the 
regulatory effects of X and M as observed by monitoring the sunAT transcript levels 
(Figure 2.3).  
Previous studies, using primer extension mapping, had suggested that the abh 
promoter region might contain multiple, closely-spaced start sites, only one of which 
was dependent on X (18). However, using 5’-RACE analysis of cDNA ends (Figure 
S2.2) we observed that transcription initiated at the identical adjacent positions, albeit 
with slightly altered frequencies, in either the sigX mutant (in which transcription 
reflects M activity) or in the sigM mutant (indicative of X activity). These results 
suggest that both of these ECF  factors recognize the same promoter sequences, 
consistent with the previously proposed consensus sequences for X and M (21).  
Sublancin expression is controlled by a complex regulatory network. Most 
antibiotics produced by B. subtilis are synthesized upon entering stationary phase or 
induced by stress or quorum sensing (reviewed in detail in (31) and (19)). It has long 
been known that antibiotic production and resistance are regulated, in a large part, by 
AbrB. Indeed, nutrient deprivation leads to a gradual increase in the phosphorylation, 
and hence activity, of Spo0A, the master regulator of sporulation (14). Mutants 
lacking spo0A are pleiotropic and also fail to express antibiotics and associated 
resistance functions. A spo0A abrB mutant strain restores regulation of antibiotic 
production, but fails to restore the ability to sporulate. It is now appreciated that abrB 
is a high affinity target for the Spo0A~P repressor and that relief of AbrB repression 
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upon nutrient depletion leads to the expression of antibacterial compounds such as 
SdpC, a toxic peptide, and the Skf cannibalism factor (12, 13, 27). 
 In addition to AbrB, the paralogous regulator Abh also plays a complex role in 
coordinating the synthesis of antibacterial compounds. Previous studies have shown 
that Abh can act both negatively and positively to affect expression of antibacterial 
compounds. Like AbrB, Abh acts as a negative regulator at the skfA and sdpA 
promoter regions (32). In contrast to AbrB, however, Abh acts positively on 
expression of sublancin as confirmed here. We have shown that the effect of abh on 
sublancin expression is epistatic to abrB and that in an abrB mutant strain, the 
requirement for abh is bypassed. Expression of abh is itself controlled by numerous 
transcription factors. As shown here, abh transcription requires the activity of either 
X or M with X as the major regulator under these growth conditions. Expression of 
abh is repressed by AbrB, which also negatively regulates its own synthesis. 
 Taken together, a complex regulatory circuitry emerges (Figure 2.6) in which 
nutritional and growth phase dependent signals converge to elevate levels of Spo0A~P 
leading to an initial repression of abrB transcription. In addition, AbrB activity is 
subject to multiple levels of post-transcriptional control including antagonism by the 
AbbA antirepressor (1), and antagonism by Abh. The latter is likely to be promoter-
specific and may reflect the overlapping DNA-binding specificity of these two 
paralogous transcription factors. Those cells that are lysogenic for SP and expressing 
either X or M, and therefore expressing Abh, will proceed to express the potent 
lantibiotic sublancin. X or M also appears to have some modest activation effect on 
sublancin production which is independent of Abh or AbrB. In addition, AbrB is 
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known to repress both sigW and many target operons for W (28). Among the operons 
under W control, the yqeZ-yqfAB operon provides a background level of resistance to 
sublancin for those cells lacking SP and therefore lacking the cognate immunity 
protein for sublancin, SunI. YqeZ encodes a putative transmembrane protease and 
YqfA and YqfB are both putative membrane anchored proteins. 
 
 
 
 
Figure 2.6. Regulatory network of sublancin synthesis and resistance in B. subtilis. 
Positive regulatory effects are indicated by straight arrows, putative positive 
regulatory effects are indicated by arrows with dash lines, and negative regulations are 
indicated by “―|”, and See text for detailed discussion. 
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2.4 Concluding remarks 
 ECF  factors are known to provide resistance against various cell envelope 
antibiotics (2, 4, 11, 21). This report establishes that ECF  factors also regulate 
antibiotic production in B. subtilis. When spotted on lawns of Bacillus spp. strains, 
strain 168 was able to inhibit the growth of various strains and this inhibition was due 
to sublancin synthesis. A double deletion of X and M eliminated the production of 
sublancin due to an inability to express Abh, an antagonist of AbrB-mediated 
repression at the sunA promoter. Indeed, both AbrB and Abh have previously been 
shown to bind to overlapping regions in the sunA regulatory region (32), but it remains 
unclear how AbrB and Abh work together to regulate sunA expression. One simple 
model suggests that Abh binding to this region (either alone or together with AbrB) 
alters the protein-DNA complex such that the promoter is now available for 
interaction with RNA polymerase. Clearly, the production of antibiotic and their 
associated resistance determinants, as here exemplified by sublancin, is subject to an 
enormously complicated control network. An ultimate, but perhaps still distant, goal 
will be to model these complex interactions to develop a predictive model of this 
regulatory circuitry. 
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2.6 Supplementary Information 
 
 
Table S2.1. List of lawn strains tested for susceptibility to compounds produced by 
strains of 168 and ∆MWX. 
 
Strains showing less susceptibility to  
∆MWX strain than strain 168 
Strains showing similar susceptibility 
to strain 168 and ∆MWX strain 
B.subtilis subsp spizizenii (2A8) * B.sphaerius WT isolate 1593 (13A1) 
B.subtilis subsp spizizenii (2A9) B.thuringiensis subsp. Thuringiensis 
NRRL-B403 (4A1) 
B.licheniformis ATCC14580 (5A36) B.thruingiensis subsp. thochigiensis 
HD868 (4Y1) 
B.atrophaeus NRS-213 (11A2) B.licheniformis 749 (5A20) 
B.atrophaeus ESM (12A1) B.cereus ATCC14579 (6A5) 
B.amyloliquefaciens FZB42 (10A6) B.sphaerius ATCC14577 (13A6) 
B.amyloliquefaciens FZB42, sfp- B.sphaerius NRS400 (13A9) 
B.pumilus ATCC7061 (8A3)   
B.licheniformis ATCC8480 (5A1)   
B.megaterium strain 899 (7A1)   
B.megaterium ATCC19213 (7A2)   
B.megaterium ATCC14581 (7A36)   
B.megaterium QMB1551 (7A16)   
B.pumilus BP1 (8A1)   
B.amyloliquefaciens NRL B-14393 
(10A5) 
  
B.atrophaeus WT isolate SB512 (11A1)   
* The Bacillus Gene Stock Center Accession number of each strain is shown in parentheses. 
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CHAPTER 3 
TRANSCRIPTOMIC AND PHENOTYPIC CHARACTERIZATION OF A 
BACILLUS SUBTILIS STRAIN WITHOUT EXTRACYTOPLASMIC FUNCTION 
SIGMA FACTORS 
 
Bacillus subtilis encodes seven extracytoplasmic function (ECF)  factors. Three (M, 
W and X) mediate responses to cell envelope active antibiotics. The functions of V, 
Y, Z, and YlaC remain largely unknown, and strong inducers of these  factors and 
their regulons have yet to be defined. Here, we define transcriptomic and phenotypic 
differences under non-stress conditions between strains carrying deletions in all seven 
ECF  factor genes (Δ7ECF), a ∆MWX triple mutant, and the parental 168 strain. Our 
results identify >80 genes as at least partially dependent on ECF  factors and, as 
expected, most of these are dependent on M, W or X which are active at a 
significant basal level during growth. Several genes, including the eps operon 
encoding enzymes for exopolysaccharide (EPS) production, were decreased in 
expression in Δ7ECF but affected less in ΔMWX. Consistent with this observation, 
Δ7ECF (but not ∆MWX) showed reduced biofilm formation. Extending previous 
observations, we also note that ∆MWX is sensitive to a variety of antibiotics and 
Δ7ECF is either as sensitive as, or slightly more sensitive than, the ΔMWX strain to 
these stressors. These findings emphasize the overlapping nature of the seven ECF  
factor regulons in B. subtilis, confirm that three of these (M, W or X) play the 
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dominant role in conferring intrinsic resistance to antibiotics, and provide initial 
insights into the roles of the remaining ECF  factors.  
The results of this study were published in Luo Y, Asai K, Sadaie Y, Helmann 
JD. Journal of Bacteriology. 2010 Nov;192(21):5736-45. 
 
3.1 Introduction 
 Bacillus subtilis harbors seven extracytoplasmic function (ECF)  factors (M, 
W, X, Y, Z, V, and YlaC) that collectively control a variety of functions related to 
cell envelope homeostasis and defenses against cell envelope-active compounds (27). 
The physiological roles of three ECF  factors (M, W, and X) have been previously 
examined, their target regulons identified, and phenotypes associated with their 
inactivation documented. Physiological functions attributable to the remaining 4 ECF 
 factors (V, Y, Z, and YlaC) are still largely unknown.  
 To date, most identified ECF  factor target genes are dependent on one or 
more of M, W, or X. Since these three  factors are all active, at least at a low level, 
during growth and their regulons overlap, we refer to these three as the MWX group. 
The W regulon is activated by various cell wall antibiotics, alkali shock, and other 
stresses affecting the cell envelope (14, 42, 49). The W regulon includes ~30 operons 
(~60 genes), many of which mediate intrinsic resistance to antimicrobial compounds. 
For example, the W-dependent fosB gene provides resistance to the cell wall-acting 
antibiotic fosfomycin (11) and the yqeZ yqfAB operon mediates protection against the 
antibiotic peptide sublancin (10). X controls several genes involved in modification 
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of the overall charge of the cell envelope including the dlt and pssA operons (12, 29). 
Deletion of sigX results in higher susceptibility to cationic antimicrobial peptides. M 
is induced by a number of stresses including high salt, heat, ethanol, acid, phosphate 
starvation, superoxide stress, and the cell wall-acting antibiotics bacitracin, 
vancomycin, and cationic antimicrobial peptides (17, 28, 36, 42, 45). A sigM mutant 
has higher susceptibility to bacitracin, paraquat and high salinity (13, 15, 36, 45). 
Genes controlled by M are important for cell wall biosynthesis and modification, 
shape determination and cell division, and detoxification, suggesting a role for M in 
maintaining cell envelope integrity in diverse environments (21).  
 There is significant overlap in recognition of target promoters amongst M, W, 
and X and this complicates attempts to clearly delineate their individual regulons. For 
example, the bacitracin resistance gene bcrC is under the dual control by M (its 
primary activator) and X (13, 36). M and X both can activate transcription of the dlt 
operon, although X is the primary activator (12, 21). The regulatory redundancy 
among ECF  factors in B. subtilis often masks the effect of single ECF  factor 
deletions. Indeed, a triple ∆MWX deletion mutant displays additional phenotypes not 
found amongst the three individual deletion mutants. These include higher 
susceptibility to several detergents and to the cell wall-acting antibiotics polymyxin B, 
D-cycloserine, and ampicillin (35). Collectively, those genes dependent on M, W, 
and/or X define the MWX regulon. Our current understanding regarding the 
physiological importance of the remaining four ECF  factors (V, Y, Z, YlaC) is 
very limited. It seems plausible that the seemingly cryptic nature of these regulators 
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may be due to the lack of well-defined inducing conditions, overlapping promoter 
recognition with other ECF  factors, or both. We refer to these as the VYZ-YlaC 
group.  
 As one approach to define the roles of each of the 7 ECF  factors, 
transcriptome analysis was previously conducted in strains after 2 hrs of induction of 
each  factor and large and often overlapping sets of genes were identified as possible 
targets (3). In a separate study, induction of V revealed a regulon comprised largely 
of previously identified members of the MWX regulon (52). This overlap might 
explain the failure to associate significant phenotypes with null mutants of sigV. In 
contrast, Y was shown to directly activate transcription from only two target 
promoters: the one that controls the sigY operon (sigY-yxlCDEFG) and one for ybgB 
(16). The functions of YlaC (37) and Z are presently unclear and their cognate 
regulons are not well defined.  
 Here, we have exploited a recently described B. subtilis strain lacking ECF  
factors (∆7ECF) (2) to identify unique transcriptional and phenotypic signatures 
associated with the four seemingly cryptic ECF  factors. Altogether, we 
identified >80 genes as at least partially ECF  factor dependent in the absence of 
artificial  factor induction. A small subset are expressed at a much lower level in 
∆7ECF when compared to ∆MWX, implying that these may be either direct or indirect 
targets for V, Y, Z, or YlaC. These genes include the eps operon, which encodes 
genes required for exopolysaccharide (EPS) production implicated in biofilm 
formation.  
 78 
3.2 Materials and Methods 
Bacterial strains and growth conditions. Strains used in this study are listed in Table 
3.1. Bacteria were grown in Luria-Bertani (LB) broth at 37°C with vigorous shaking 
or on solid LB medium containing 1.5% Bacto agar (Difco). The following antibiotics 
were used for selection when necessary: spectinomycin 100 g/mL, kanamycin 10 
g/mL, chloramphenicol 10 µg/mL, tetracycline 5 µg/mL, and erythromycin 1 µg/mL 
with lincomycin 25 µg/mL (mls: macrolide-lincomycin-streptogramin B resistance).  
Gene deletions were generated by replacing genes with antibiotic resistance 
cassettes using long-flanking-homology PCR as described (36, 48). Chromosomal 
DNA transformation was performed as described (26). The ∆7ECF strain contains 
unmarked deletions of all seven ECF  factor-encoding genes as previously described 
(2). 
RNA preparation and microarray analyses. Cultures of stains 168, ∆MWX, and 
∆7ECF were grown to mid-log phase (OD600 of 0.4). Total RNA was isolated from 
three different biological replicates with the RNeasy Mini Kit (Qiagen Sciences, 
Maryland). After DNase treatment with TURBO DNA-freeTM (Ambion), RNA 
concentrations were quantified using a NanoDrop spectrophotometer (NanoDrop Tech. 
Inc., Wilmington, DE). cDNA labeling and microarray analysis were performed as 
described (24). Three microarrays with biological triplicates were performed for each 
microarray comparison. Images were processed and normalized using the GenePix Pro 
4.0 software package which produces (R, G) fluorescence intensity pairs for each gene. 
Each expression value is represented by at least six separate  
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Table 3.1. B.subtilis strains used in this study. 
Strains Genotype  Construction or reference 
168 trpC2 Lab strain 
CU1065 trpC2 attSP Lab strain 
JH642 trpC2 pheA1 (5) 
NCIB3610  undomesticated wild strain  Lab strain 
HB10107  168 sigM::tet sigX::kan sigW::mls   (34) 
BSU2007 168 ∆sigM ∆sigX ∆sigW ∆sigY ∆sigV ∆sigZ 
∆ylaC   
(2) 
HB0009  CU1065, sigY::mls (16) 
HB0911  CU1065 sigV::cat (35) 
HB0915 CU1065 ylaC::spec (35) 
HB0032  CU1065 sigZ::kan (15) 
HB10101 168 sigV::cat ChrDNA HB0911168 
HB10108 168 sigY::mls ChrDNA HB0009 168 
HB10109 168 sigZ::kan ChrDNA HB0032 168 
HB10233 168 ylaC::spec ChrDNA HB0915168 
HB10234 168 sigY::mls ylaC::spec ChrDNA 
HB10108HB10233 
HB10235 168 sigZ::kan sigV::cat ChrDNA 
HB10109HB10101 
HB10236 168 sigV::cat sigY::mls sigZ::kan ylaC::spec ChrDNA 
HB10234HB10235 
YC125 NCIB3610 ΔepsH::tet amyE::PlutA-lacZ (cat)  (18) 
HB10223 168 epsH::tet ChrDNA YC125 168 
HB10158 168 amyE::Pspac-abh (cat) ChrDNA BZH73168 
HB10224 168 ∆sigM ∆sigX ∆sigW ∆sigY ∆sigV ∆sigZ 
∆ylaC  amyE::Pspac-abh (cat) 
ChrDNA HB10158 
BSU2007 
HB10225 168 sigM::tet sigX::kan sigW::mls   
amyE::Pspac-abh (cat) 
ChrDNA HB10158 
HB10107 
JMA208 JH642 immR::cat (5) 
JMA222 JH642 ICEBs10/cured of ICEBs1 (5) 
BZH73 JH642 abh::kan  amyE::Pspac-abh (cat)      
thrC:: PsunA-lacZ (spec)  
(44) 
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measurements (duplicate spots on each of three arrays). Mean values and standard 
deviations were calculated with MS Excel. The normalized microarray datasets were 
filtered to remove those genes that were not expressed at levels significantly above 
background in either condition (sum of mean fluorescence intensity <20). In addition, 
the mean and standard deviation of the fluorescence intensities were computed for 
each gene and those where the standard deviation was greater than the mean value 
were ignored. The fold induction values were calculated using the average signal 
intensities from the three arrays with strains within microarray experiment pairs. 
 The complete set of raw and normalized data for each of the triplicate DNA 
microarray experiments involving strains B. subtilis 168, ∆MWX and ∆7ECF is 
available at the Gene Expression Omnibus database ( http://ncbi.nlm.nih.gov/geo/) 
under accession no. GSE22930. 
Hierarchical Clustering analysis. Genes with at least 3 fold change in at least one 
microarray comparison pairs were subjected to hierarchical clustering analysis with 
Gene Cluster 3.0 software (22). The log2 ratios of fold changes were used, and the 
resulting cluster was visualized with Treeview 1.60 (22). 
Phenotype microArray and disk diffusion. Phenotype MicroArrayTM (PM) assays 
were performed by Biolog (Biolog Inc. CA.). The Biolog plates used for these 
analyses were PM1~PM20 as described on the Biolog web site 
(http://www.biolog.com/PM_Maps.html). Cell growth was monitored by measuring 
the respiration-dependent color change of Biolog Redox Dye D in each well. 
Incubation and recording of phenotypic data was performed in the OmnilogTM -Station. 
A time course for dye color formation (respiration) for cells was generated and the 
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difference in growth rates between different strains was calculated using the Omnilog 
software. The growth differences were reported as arbitrary units. Positive values 
indicate that the mutant showed greater rates of growth (or respiration) than the 
control wild type strain. The negative value indicates the mutant showed lower growth 
(or respiration) rate than the control wild type strain. The PM assay was performed 
twice. The average values of these two independent experiments were reported and 
used for further analysis. The significant hits (as defined by Biolog) are listed in Table 
S3.1 (supplementary information) for the ∆MWX versus 168, and ∆7ECF versus 168 
comparisons. The original PM data is available upon request. 
 Disk diffusion was performed as described (35). Briefly, strains of 168, 
∆MWX and ∆7ECF were grown to mid-log phase (OD600 of 0.4) in LB medium at 
37°C with aeration. A 100 μl aliquot of these cultures was mixed with 4 ml of 0.7% 
LB soft agar (kept at 50°C) and directly poured onto LB plates (containing 15 ml of 
1.5% LB agar). The plates were then dried for 20 min in a laminar airflow hood. Filter 
paper disks containing the chemicals to be tested were then placed on the top of the 
agar and the plates were incubated at 37°C overnight. The next day, the diameters of 
the inhibition zones (clearance) were measured. The zones of inhibition were reported 
after subtraction of the diameter of the filter paper disk (6.5 mm). The following 
chemicals and quantities were used in the disk diffusion assays: dodecyltrimethyl 
ammonium bromide (DTAB) 250 µg, triton X-100 5µl of 10% solution, amitriptyline 
250 µg, polymyxin B 50 µg, bacitracin zinc 250 µg, fosfomycin 500 µg, ampicillin 10 
µg, penicillin G 10 unit, aztreonam 30 µg, cefuroxime 30 µg, ciprofloxacin 50 µg, 
ofloxacin 10 µg, zinc chloride 500 mM, and polymyxin B 50 µg. 
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Biofilm formation microtiter plate assay. Biofilm formation assays were performed 
as described (25, 33) with modifications. B.subtilis strains were grown in Biofilm 
Growth (BG) medium, which is LB broth supplemented with 100 mM MOPS (pH 7.0), 
1 mM MgSO4 and 0.1% glucose. IPTG (1 mM, final concentration) was added when 
required. Exponentially growing cultures (OD600, 0.4) were diluted to an OD600 of 0.01 
with BG medium, and 100 µl aliquots of the freshly inoculated medium were 
dispensed into wells of a 96-well polyvinyl chloride microtiter plate (Falcon 353911 
flexible U-bottom plates, Becton-Dickinson Labware). Cells were statically incubated 
at 37°C for 65 hours. Cells were aerated by pipetting up and down twice every 12 
hours; the BG medium with planktonic cells was replaced with fresh BG media every 
24 hours. After 65h incubation, the unbound planktonic cells were removed by gentle 
aspiration. The wells with adherent biofilm cells were gently rinsed twice with 100 µl 
washing buffer (100 mM MOPS, 1 mM MgSO4, pH7.0), followed by heat fixation at 
70°C for 10 min, and stained with 200 µl per well of 1% crystal violet (dissolved in 
washing buffer) for 20 min. The wells were rinsed under running deionized water after 
staining. The bound cystal violet stains were solubilized with 200 µl of ethanol-
acetone (4:1, vol./vol.) for 20 min. The solutions were transferred to a fresh 96 well 
polystyrene plate, and absorbance measured at OD570 using a Tecan Rainbow 
microplate reader. Biological triplicates of each strain were assayed in 21 wells in the 
same plate, and the biofilm assays were performed at least three times. The data from 
the “same day” experiments were reported.  
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3.3 Results and Discussion 
Identification of genes regulated by ECF  factors using cDNA microarray 
analysis. Previous microarray analyses have been reported for either some single 
mutant strains or over-expression of single  factors (sigW, sigX, sigM, and sigY) (12, 
14, 16, 21), but these studies likely missed some targets that can be transcribed by 
more than one ECF  factor. Other studies have investigated transcriptome changes 
after prolonged (2 hrs) artificial  factor induction, but the significance of these 
preliminary findings has not been further investigated (3). Whereas regulon overlap 
has emerged as a significant confounding factor in assigning ECF  regulons in B. 
subtilis (35), there is no evidence to date of  cascades in which one ECF  acts 
indirectly by activating transcription of another in B. subtilis. Six of seven ECF  
factor (except σZ) are encoded in operons that are thought to be largely autoregulated 
under inducing conditions (51). It is within this conceptual framework that we have 
sought to define the roles of ECF  factors. 
 Here, we set out to identify genes that are at least partially dependent on one or 
more ECF  factors during growth and, further, to identify those genes or functions 
that might be dependent on the less studied  factors: V, Y, Z, and YlaC (the VYZ-
YlaC group). We carried out cDNA microarray analyses for logarithmically growing 
cells (LB medium) with strains 168 (wild type, WT), a strain with null mutations in 
three ECF  factor genes (sigM, sigW, and sigX; ∆MWX), and a mutant strain 
harboring null mutations of all 7 ECF  factors (∆7ECF). Genes that are dependent 
only on M, W and/or X (the MWX regulon) should be expressed at a lower level in 
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both ∆MWX and ∆7ECF when compared to WT, but should remain unchanged in the 
comparison of ∆7ECF versus ∆MWX. Genes that are largely dependent on V, Y, Z, 
and/or YlaC should be expressed at a lower level in ∆7ECF versus WT, and ∆7ECF 
versus ∆MWX, but remain relatively unchanged in the ∆MWX versus WT 
comparison.  
As expected, the expression of many of the known MWX regulon members 
was reduced in strain ∆MWX relative to WT, whereas the known autoregulated 
operons encoding Y and YlaC remained unchanged (Figure 3.1A). In the comparison 
between ∆7ECF and WT, the known regulons of M, W, X, Y and YlaC were 
reduced in expression, as expected (Figure 3.1B). In the comparison between strains 
∆7ECF and ∆MWX (Figure 3.1C), a majority of MWX dependent genes remained 
unchanged. This indicates that, under these growth conditions, the other four ECF  
factors (V, Y, Z, and YlaC) contribute little to the expression of the MWX regulon. 
These transcription patterns match well with expectations based upon previously 
published reports regarding ECF  regulon composition (35).  
Some known MWX regulon genes did not display differential expression in the 
comparisons between ∆MWX versus WT, and ∆7ECF versus WT (Figure 3.1A and 
3.1B). This likely reflects the fact that these genes were previously assigned as ECF -
dependent under inducing conditions, such as treatment with antibiotics, and they may 
not be significantly dependent on ECF  factors under the non-stress conditions of the 
current study (due, for example, to the presence of promoters recognized by non-ECF 
 factors). Presumably, only genes that are strongly dependent on ECF   
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Figure 3.1. Scatter plot of cDNA microarray analyses. The average signal intensities 
of each microarray experiments were plotted. The known regulons of M W X, Y 
YlaC, genes of eps operon, and ICEBs1 elements are differentially labeled.  
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factors for their basal expression during log phase will show significant differences in 
our analysis.   
In order to further delineate the regulons of these ECF  factors, we performed 
a hierarchical clustering analysis with genes displaying significant differences in 
expression (>3 fold changes) in at least one of the three microarray comparisons 
(Figure 3.2). Clustering is an un-supervised method, with no assignment of regulon 
information before the analysis. Since ECF  factors are positive regulators, we 
focused on genes that were reduced in expression in the absence of ECF  factors. 
Based on the clustering analysis and expression pattern, we further classified genes 
into three categories: target genes for MWX, targets of Y and YlaC, and additional 
targets significantly reduced in ∆7ECF compared to ∆MXW (Table 3.2). The latter 
group of genes presumably includes genes dependent on one or more of the poorly 
characterized VYZ -YlaC group of ECF  factors, either alone or together with MWX. 
Under these growth conditions we did not detect signals in the microarray for either 
sigV or sigZ. This suggests that these  factors are expressed poorly if at all and 
therefore their contribution to gene expression is likely to be minimal. When genes 
within an operon were located in a different section of the cluster, the average fold 
change for the operon was used for assigning the apparent regulon.  
The MWX target genes. Thirty two genes were classified as putative MWX target 
genes since their expression was significantly reduced in both the ∆MWX and ∆7ECF 
strains when compared to WT, while there was little difference in the ∆MWX versus 
∆7ECF comparison. The majority of these genes were previously identified as MWX 
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regulon members, thereby validating our experimental approach. This analysis did 
identify three new candidate MWX target genes: yxiT, yhjA and des. 
Both yxiT and yhjA are unknown function genes that encode small peptides. 
Typical MWX promoter sequences were not found upstream of either gene, suggesting 
that their regulation by MWX is likely to be indirect. The des gene, encoding a delta5 
lipid desaturase (1), is induced by the DesKR two component system in response to 
conditions that reduce membrane-fluidity (19, 20). No candidate MWX-type promoters 
were found within 1kb upstream of either des or desKR, suggesting that reduced 
expression in the sigMWX mutant may be an indirect consequence of altered 
membrane homeostasis. For example, the MWX regulon is known to include enzymes 
for phospholipid synthesis (pssA and psd (12)), lipoteichoic acid synthesis (yfnI (21, 
30)), and D-alanylation of teichoic acids (the dltABCDE operon (12, 21)). Whether 
altered transcription of some or all of these genes contributes to the observed des 
induction is presently unknown.  
The Y and YlaC target genes. We detected 36 genes that closely cluster with the 
autoregulated sigY operon and the ylaC gene. Based on this clustering, and the 
apparent lack of V and Z expression under these conditions, these genes were 
classified as putative Y and YlaC target genes. These genes showed less than 2-fold 
change when comparing their expression in strain ∆MWX and WT, but more than 3-
fold change in the comparisons between the ∆7ECF and WT strains, or the ∆7ECF and 
∆MWX strains, or both (Table 2). Previously published information regarding Y  
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Figure 3.2. Hierarchical clustering analysis of genes that are down regulated at least 
three fold in at least one of the three microarray analyses. Green indicates down 
regulation, and red indicates up regulation. The known ECF  regulon are indicated by 
the * M,W,X,Y,YlaC followed the gene names. 
  
 90 
 
 91 
 
 
 
 
 
 
 
 
 
 
Table 3.2. Genes that are reduced at least 3 fold in at least one of the three microarray 
comparisons: ∆MWX vs. WT, ∆7ECF vs. WT, and ∆MWX vs. 7ECF.  
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Gene 
/Operona 
Fold changes Regulatorb Functionsc 
∆MWX/
WT 
∆7ECF/
WT 
∆7ECF 
/∆MWX 
 
 MWX target genes  
sigM 0.03 0.02 1.0 M ECF σ factor M  
sigX 0.03 0.04 1.0 X ECF σ factor X 
sigW 0.04 0.01 1.0 W ECF σ factor W 
abh 0.02 0.03 1.3 MWX Transcriptional regulator 
yjbD (spx) 0.2 0.2 1.0 MWX Redox-sensitive regulator 
enzyme; anti-alpha, global 
transcriptional regulator 
dltABCDE 0.03 0.03 1.0 MX dltABCDE operon; D-
alanylation of teichoic acids 
maf 0.1 0.1 0.7 M Putative septum formation 
DNA-binding protein 
radC (ysxA) 0.1 0.1 1.0 M Putative DNA repair protein 
rapD 0.2 0.2 0.6 M Response regulator aspartate 
phosphatase 
yebC 0.2 0.2 0.9 M Putative integral inner 
membrane protein 
yngC 0.3 0.2 0.8 M Putative integral inner 
membrane protein  
yceC 0.3 0.2 0.8 M Putative stress adaptation 
protein 
yfnI 0.4 0.2 1.3 M Similar to lipoteichoic acid 
synthase 
yeaA 0.01 0.01 1.0 W Unknown 
yqeZ yqfAB 0.03 0.03 1.0 W Sublancin resistance 
ydbST 0.1 0.1 1.0 W Unknown 
yvlABCD  0.1 0.2 1.0 W Unknown 
sppA 0.2 0.1 0.9 W Signal peptide peptidase 
yteJ 0.2 0.1 1.1 W Putative integral inner 
membrane protein 
yaaN 0.2 0.3 0.8 W Unknown 
lytR 0.4 0.2 0.9 X Membrane-bound 
transcriptional regulator 
yxiT 0.1 0.1 0.8  Unknown 
des 0.2 0.4 1.2 DesKR Fatty acid desaturase 
yhjA 0.6 0.3 0.9  Unknown 
 
ECF target genes 
yrhI (bscR) 0.4 0.2 0.03 MX Transcriptional regulator of 
cypB 
rodA 0.3 0.3 0.2 M Cell-division membrane protein 
ywtF 0.6 0.3 0.5 M Transcriptional regulator; LytR 
family 
ythP 0.1 0.03 0.2 W Putative ABC transporter  
ybfO 0.1 0.1 0.4 W Putative exported hydrolase 
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Table 3.2 (Continued) 
Gene 
/Operona 
Fold changes Regulatorb Functionsc 
∆MWX/
WT 
∆7ECF/
WT 
∆7ECF 
/∆MWX 
sunA-sunT-
bdbA-yolJ-bdbB 
0.1 0.06 0.3 Abh Sublancin 168 prduction, 
modification and transportation  
epsABCDEFG
HKJKLMNO 
0.4 0.2 0.2 SinR/ 
AbrB 
Exopolysaccharide 
biosynthesis.  
tasA 0.2 0.1 0.5 SinR Major protein component of 
biofilm matrix 
pel 0.5 0.1 0.3 TnrA Pectate lyase 
yjhA 0.6 0.3 0.6  Similar to  putative lipoprotein 
 
Y YlaC target genes 
sigY 0.8 0.008 0.003 Y ECF σ factor Y 
yxlCDEFG 0.8 0.1 0.07 Y sigY yxlCDEFG operon; 
negatively regulator of Y 
ylaC 0.8 0.4 0.5 YlaC ECF σ factor YlaC 
ybgB 1.0 0.5 0.1 Y Unknown 
yddK 0.9 0.0002 0.0004  ICEBs1 gene 
yddM 0.9 0.005 0.008  ICEBs1 gene; putative helicase  
ydcN (immR) 1.7 0.1 0.01  ICEBs1 gene; transcriptional 
regulator (Xre family) 
ybdN 1.3 0.3 0.03  Homologous to antimicrobial 
protein YbdN in Bacillus 
licheniformis 
yolA 0.6 0.2 0.3  sp prophage genes; secreted  
yolB 0.8 0.1 0.3  sp prophage gene 
ysbAB 0.6 0.2 0.2  Homologous to lrgAB  in 
Staphylococcus aureus 
ykuA (pbpH) 0.7 0.2 0.2  Penicillin binding protein (class 
B)  
yqeB 0.7 0.3 0.2  Putative membrane protein 
ytzE 0.6 0.3 0.3  Similar to transcriptional 
regulator (DeoR family) 
ptb-bcd-buk-
lpdV-bkdAA-
bkdAB-bkdB  
1.4 0.3 0.3 CodY/ 
bkdR/ 
L 
Degradation of the branched-
chain amino acids leucine, 
isoleucine and valine 
yppF 0.9 0.4 0.3 Spo0A Unknown 
ecsA 0.9 0.4 0.3  ABC transporter (ATPase )  
yjcOPQ  1.2 0.4 0.3 D Unknown 
yjcM 1.9 0.3 0.2 Spo0A 
 
Similar to alcohol 
dehydrogenase and to coat-
associated protein YhbB 
yybNMLK  1.2 0.5 0.2 Rok Unknown 
yweA 1.8 0.3 0.1  Unknown 
ykuV 1.2 0.4 0.3  Thiol:disulfide oxidoreductase, 
membrane protein 
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Table 3.2 (Continued) 
Gene 
/Operona 
Fold changes Regulatorb Functionsc 
∆MWX/
WT 
∆7ECF/
WT 
∆7ECF 
/∆MWX 
 
gntP 1.2 0.5 0.3  Gluconate permease 
yclJ 1.2 0.6 0.2  Putative response regulator of 
YclJK two-component 
regulatory system.  
yvrPON  2.1 0.5 0.2  Similar to ABC transporter 
a.  Genes in operons are shown in bold. The fold change for an operon is the average of fold 
changes of genes in bold in the table. 
b.  M refers to M, W refers to W, X refers to X, and Y refers to Y.  
c. Function annotation are mainly based on GenoList (http://genodb.pasteur.fr/cgi-
bin/WebObjects/GenoList) (6). 
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and YlaC regulon composition is quite sparse, though we do detect the sigY operon 
and the ybgB gene, the only confirmed target operons of Y to date (16). Several genes 
previously identified as putative Y or YlaC regulon members based on microarray 
experiments using strains harboring a single IPTG inducible ECF  gene (either Pspac-
sigY or Pspac-ylaC) (3) were not detected in our analysis, possibly due to the 
differences in experimental conditions and strain backgrounds. 
Operons affected by Y or YlaC include: ysbAB, ptb-bcd–buk, yjcOPQ, 
yybNMLK, and yvrPON. Several of these genes are known to be regulated by other 
regulators, such as Spo0A, Rok, and L (Table 3.2). Whether their regulation by ECF 
 factors (as detected in our experiments) is independent of other regulators is not 
known. Four genes with annotated functions (ykuA, ecsA, ykuV and gntP) and 8 genes 
of unknown function (yolA, yolB, yqeB, ytzE, yppF, ybdN, yweA, and yclJ) were also 
identified as potential Y and/or YlaC regulon members.  
The most dramatic changes in the ∆7ECF strain were a loss of signal for three 
genes (immR (formerly ydcN), yddM and yddK) within the integrative and conjugative 
element ICEBs1 that is inserted into the trnS-leu2 region (5). This suggested a possible 
loss of the ICEBs1 element in the ∆7ECF strain (Figure 3.1) which was confirmed by 
PCR: two ICEBs1 genes immR and yddE were easily detected in the WT strain and 
∆MWX, but no products were detected in the ∆7ECF strain (data not shown). Since 
strains ∆7ECF and ∆MWX were constructed in different labs using different methods, 
we asked whether the loss of ICEBs1 was a random incident, or related to the multiple 
ECF  factor deletion events in strain ∆7ECF. To address this question, we compared 
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the excision rates of ICEBs1 amongst strains 168 (WT), ∆MWX, ∆VYZ-YlaC, 
JMA208 (as a positive control) and JMA222 (as a negative control) using linear-range 
PCR according to (4, 5). No ICEBs1 excision events were detected in strains of 168, 
∆MWX or ∆VYZ-YlaC, suggesting that excision is not triggered by either of these 
multiple deletions (data not shown). This result does not exclude the possibility that 
loss of all seven ECF  factors might somehow trigger excision. In general, the genes 
encoded in ICEBs1 are mainly involved in ICEBs1 excision and transfer (or are of 
unknown function). Since most of the phenotypes associated with the ∆7ECF strain 
are shared with the ∆MWX strain (which retains ICEBs1), we infer that these 
phenotypes are due to the loss of ECF  factors and not to the loss of the ICEBs1 
element. 
Putative ECF target genes. There are 19 genes down-regulated in all three 
microarray comparisons, indicative of the involvement of ECF  factors from both 
groups (MWX and the VYZ-YlaC) in their expression. These genes are assigned as 
putative ECF regulon members. Of these 19 genes, five genes (yrhI, rodA, ywtF, ythP, 
and ybfO) have been previously assigned as MWX regulon members. Deletion of all 
7ECF  factors reduced their expression compared to the ∆MWX deletion. Another 
gene (pel) is only reduced ~2 fold in expression in strain ∆MWX versus WT, with a 
significant reduction also noted in the comparisons ∆7ECF versus WT and ∆7ECF 
versus ∆MWX.  The pel gene encodes pectate lyase (EC 4.2.2.2), whose transcription 
is regulated by A and repressed by TnrA (40, 50). We could not identify a MWX 
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promoter element upstream of the translational start site of pel, suggesting that its 
regulation by ECF  factors may be indirect. 
Of the 22 putative ECF regulon genes, eleven are organized into two operons, 
the sublancin operon and the eps operon. Three genes of the sublancin operon, sunT, 
bdbA, and bdbB were down-regulated in all three microarray analyses, suggesting 
complex regulation of this operon. The sublancin operon is located in prophage SP, 
and is involved in the production, modification and secretion of the lantibiotic 
sublancin 168 (41). Transcription of the sublancin operon is primarily regulated by the 
transcriptional regulator Abh, whose transcription is largely dependent on X, and to a 
lesser degree on M (34). Sublancin production is known to be reduced in strains 
lacking X and M and the present analysis reveals an even greater reduction in strain 
∆7ECF. This result suggests that sublancin production is not only subject to primary 
regulation by X and M, but also by other (VYZ-YlaC group) ECF  factors. The 
expression of abh was similar in strains ∆7ECF and ∆MWX, suggesting that this 
additional regulation may be independent of Abh. Consistent with this idea, we 
previously detected residual expression of sublancin in an abh null mutant (34).  
The largest operon detected in our microarray analysis was the eps operon 
consisting of genes epsABCDEFGHIJKLMNO (formally yveKLMNOPQRST 
yvfABCDEF). Eight genes within this operon exhibited on average 2.5 fold lower 
expressions in strain ∆MWX versus WT, 5 fold lower expression in strain ∆7ECF 
versus WT, and 5 fold lower expression in strain ∆7ECF versus strain ∆MWX, 
suggesting the involvement ECF factors in expression. The eps operon encodes 
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exopolysaccharide synthesis enzymes, and is essential for biofilm formation in 
B.subtilis (7). Interestingly, the expression of another major biofilm gene tasA was 
also significantly reduced in all three comparisons. TasA is major protein component 
of biofilm matrix (9), and has recently found to form amyloid fibers in B. subtilis (43). 
The down-regulation of these biofilm genes suggests that ECF  factors regulate 
biofilm formation. Previous work has shown that deletion of sigX, as well as a triple 
deletion of sigMWX in an undomesticated strain background (NCIB3610), resulted in 
reduced biofilm formation (35, 39). The reduced transcription of essential biofilm 
genes that we note provides a plausible genetic basis for these earlier observations.  
Overlapping regulation of ECF  factors in biofilm formation. Our analysis 
suggests that multiple ECF  factors may play a role in biofilm formation. To explore 
the involvement of ECF  factors in biofilm formation, WT, ∆MWX, and ∆7ECF 
strains, and a strain harboring a quadruple deletion of sigY, sigV, sigZ, and ylaC 
(∆VYZ-YlaC) were tested for their ability to form biofilms using a microtiter plate 
assay (Figure 3.3). A strain harboring a null mutation in epsH (∆espH) was used as 
negative control. The ∆VYZ-YlaC strain only slightly reduced biofilm formation 
(P=0.03), while the triple mutant strain ∆MWX was modestly, but reproducibly, 
reduced in biofilm formation. The most dramatic reduction in biofilm formation was 
observed with stain ∆7ECF (Fig. 3.3A). These results suggest that MWX are major 
factors regulating biofilm formation, and that VYZ YlaC may have residual and additive 
effects. Recently Murray et al. reported that X is involved in controlling biofilm 
architecture in strain NCIB3610 through Abh, and that over-expression of Abh could 
compensate for the loss of sigX (39). We tested whether over-expression of Abh could  
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also restore biofilm formation in both strains ∆MWX and ∆7ECF. Over-expression of 
Abh was able to restore biofilm formation in strain ∆MWX, but not in strain ∆7ECF 
(Figure 3.3B). There was no growth defect for these strains in the biofilm growth 
media (data not shown), indicating that these effects are specific for biofilm formation. 
Together, these results suggest that there are ECF  target genes, other than Abh, that 
affect biofilm formation. In light of the large number of cell envelope processes 
affected by ECF  factors, this result is perhaps not surprising. 
Biolog Phenotype Microarray. ECF  factors play important roles in maintaining 
cell envelope integrity and contribute to resistance against cell-envelope acting 
antibiotics and other chemicals. Single deletions of sigM, sigW or sigX alone have 
shown high susceptibility to a variety of cell envelope stresses (12, 13, 15, 36, 45), and 
the ∆MWX triple mutant displayed additional sensitivities not seen with the single 
mutants (35). We hypothesized that the deletion of all 7 ECF  factors might give rise 
to additional phenotypes. To test this idea, we employed a phenotype microarray (PM) 
analysis to screen for phenotypes associated with strains ∆7ECF and ∆MWX. PM 
analysis is a high throughput approach to screen for novel phenotypic traits linked to 
genetic alterations (8, 38, 47). Our PM tests included 960 assays for carbon, nitrogen, 
phosphorus and sulfur source utilization, nutrient stimulation, pH and osmotic stresses, 
and 240 assays for chemical sensitivities. Similar to the strategy used in the 
microarray analysis, two PM analyses were performed to screen for the phenotypic 
differences between strains ∆7ECF and WT, and between strains ∆MWX and WT. 
Our goal was to detect phenotypes associated with not only MWX, but also the lesser 
understood VYZYlaC factors. The significant phenotypic differences between strains 
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∆MWX versus WT and ∆7ECF versus WT are summarized in Table S3.1 
(supplementary information). 
 As expected, strain ∆MWX displayed resistance to tetracycline, kanamycin 
and erythromycin (and related antibiotics doxycycline, chlortetracycline, 
demeclocycline, rolitetracycline, oleandomycin, troleandomycin, neomycin, and 
paromomycin) owing to the use of these resistance cassettes to delete the genes 
encoding ECF  factors in strain ∆MWX. As strain ∆7ECF carries unmarked deletions 
(2), this strain did not display these resistances. Relative to the WT strain and to 
∆MWX, strain ∆7ECF displayed similar susceptibility to sisomicin (aminoglycoside), 
and higher susceptibility to chlorpromazine (phenothiazine), and chelerythrine (protein 
kinase C inhibitor).  
 In the tests for nutrient utilization, no growth differences were detected in 
either mutant strain with regards to carbon, phosphorous, and sulphur source 
utilization. However, utilization of a wide range of amino acids as a nitrogen source 
was impaired with both mutant strains relative to WT. Original growth kinetics from 
the PM analysis indicated that both mutant strains either failed to grow or grew poorly 
under these conditions relative to the WT strain. Although Y has been reported to be 
induced under nitrogen starvation conditions (46), we did not detect a significant 
difference between strains ∆MWX and ∆7ECF with regard to nitrogen source 
utilization in the PM analysis.   
 We identified a variety of new antibiotics and chemicals that strongly inhibit 
the growth of strains ∆MWX and ∆7ECF. These antibiotics could be further classified 
into 3 major categories based on their mode of action: cell envelope inhibitors, DNA 
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synthesis inhibitors, and toxic ions. To confirm these results, we tested many of these 
chemicals using disk diffusion assays (Figure 3.4). In addition, we also tested several 
other antibiotics and chemicals (polymyxin B, bacitracin, fosfomycin, ampicillin, and 
triton X-100) previously shown to have ECF  factor-related resistance determinants.  
MWX are the major ECF  factors involved in cell envelope stress susceptibility. 
In the disk diffusion assay, all test compounds, except for protamine sulfate, inhibited 
the growth of both strains ∆MWX and ∆7ECF relative to the WT strain (Figure 3.4). 
Protamine sulfate did not inhibit any of the strains (data not shown). It is possible that  
a different growth condition may be required to detect the susceptibility differences to 
protamine sulfate. Results from the disk diffusion assays differed from the PM 
analysis with three chemicals: the antibiotics aztreonam and ofloxacin and ZnCl2. The 
PM analysis suggested an increase in resistance to these chemicals in strain ∆MWX, 
but the disk diffusion analysis demonstrated an increase in sensitivity to these 
chemicals for both strains ∆MWX and ∆7ECF when compared with the WT strain. 
This may reflect differences in the growth conditions between the PM assay and the 
disk diffusion assay.  
Of the 13 compounds tested by disk diffusion, the most dramatic changes in 
susceptibility were observed with cell wall acting-antibiotics fosfomycin, bacitracin, 
aztreonam and cefuroxime. ECF  factor-dependent resistance to fosfomycin and 
bacitracin has been previously documented, and two genes, fosB (W regulon) (11) 
and bcrC (MX regulon) (13) mediate this resistance.  
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Aztreonam and cefuroxime are ß-lactam antibiotics that competitively inhibit 
the peptidoglycan transpeptidase activities of penicillin binding proteins (PBPs) to 
inhibit cell wall synthesis. Aztreonam specifically inhibits the cell division protein 
PBP3 in E.coli (23), but its target(s) in B.subtilis is unknown. Although active against 
most gram negative bacteria, aztreonam is generally considered ineffective against 
gram positive bacteria. Consistent with this notion, we did not observe a zone of 
inhibition using aztreonam against WT cells. However, the deletion of sigMWX (as 
well as the deletion of all 7 ECF  factors) rendered B.subtilis highly sensitive to this 
drug, suggesting the involvement MWX in the bacterium’s innate resistance 
mechanisms. Deletion of sigMWX also significantly increased cell susceptibility to 
cefuroxime even though the WT cells are quite sensitive already. The resistance 
mechanisms to these two ß-lactam antibiotics and their association with ECF  factors 
are unknown, and currently under investigation.  
 In addition, we found strains ∆MWX and ∆7ECF had increased susceptibility 
to three other chemicals, including dodecyltrimethyl ammonium bromide (DTAB), 
amitripyline, and ZnCl2. DTAB is one of the most widely used cationic surfactants in 
chemical industries (31). Amitripyline is commonly used as antidepressant, and its 
detergent properties allow partitioning into lipid bilayers, and contribute to its toxicity 
to mammalian neurons (32). Previous work has already demonstrated that a ∆MWX 
strain (in a strain NCIB3610 background) is more highly sensitive to the detergents 
Triton X-10 and SDS (35). In addition, strains ∆MWX and ∆7ECF are more sensitive 
to the toxic ion Zn. The reason for this effect is unknown. Finally, our data also 
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confirms previous observations (35) that MWX influences resistance to three other cell 
envelope-acting antibiotics, ampicillin, penicillin G and polymycin B.  
For most of antibiotics tested in our analysis, there were no significant 
sensitivity differences between the ∆MWX and ∆7ECF strains (Figure 3.4) indicating 
that MWX are the major ECF  factors involved in the cell envelope stress resistance, 
except for one cephalosporin (cefuroxime) and two DNA topoisomerase inhibitors 
(ciprofloxacin and ofloxacin). Slightly higher susceptibility to cefuroxime were found 
in strain ∆7ECF than strain ∆MWX. In the case of ciprofloxacin and ofloxacin, only 
strain ∆7ECF is significantly susceptible to both drugs. Further disk diffusion tests 
with the single deletions of each of the sigVYZ ylaC factors, or a quadruple mutant did 
not display difference in susceptibility to these three drugs when compared to WT 
(data not shown). We suspect that a complex overlapping regulation by some 
combination of MWX and VYZ YlaC factors are required for optimal resistance in WT 
cells.  
 
3.4 Concluding Remarks 
We here describe transcriptomic and phenotypic differences among B. subtilis strains 
lacking key subsets of ECF  factors. Using microarray comparison experiments, we 
identified 87 genes controlled by one or more ECF  under these non-stressed 
conditions. Many of these are previously known ECF target genes, whereas most 
others of the newly identified target genes lack apparent ECF promoters, suggesting 
that their regulation may be indirect. Indeed, ECF  factors are known to activate the 
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expression of several known or putative transcription factors. In addition to 
confirming and extending previous findings regarding the contribution of ECF  
factors to cell envelope stress resistance, the comparisons here provide evidence for a 
role of ECF  factors in biofilm formation and, using phenotypic microarrays, we 
identify a major role for ECF  factors in resistance to ß-lactam antibiotics such as 
aztreonam and cefuroxime. 
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3.6 Supplementary Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S3.1.  Phenotype MicroArrray analysis of strains ∆MWX or ∆7ECF vs. WT.  
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Compound a ΔMWX   vs. WT b 
Δ7ECF  
vs. WT b Mode of action
 c 
 
Cell envelope stress 
Cefuroxime * -148   Wall, cephalosporin 
Aztreonam * 139   Wall, lactam 
DTAB *   -127 membrane, detergent, cationic 
Lauryl sulfobetaine -110 -112 membrane, detergent, zwitterionic 
Niaproof -115 -103 membrane, detergent, anionic 
Poly-L-lysine   -80 membrane, detergent, cationic 
Amitriptyline *   -127 membrane, transport 
Protamine Sulfate *   -113 membrane, ATPase 
 DNA synthesis 
Lomefloxacin   -130 DNA topoisomerase (GP); 
fluoroquinolone 
Pipemidic Acid   -109 DNA topoisomerase (GP), quinolone  
Ciprofloxacin *   -89 DNA topoisomerase, quinolone 
Ofloxacin * 120 -88 DNA topoisomerase (GP); 
fluoroquinolone 
 Toxic ions 
Thallium (I) acetate -153 -169 toxic cation 
Zinc chloride * 265 120 toxic cation 
Sodium Tungstate -205   transport, toxic anion, molybdate 
analog 
Protein synthesis  
Tetracycline 220  protein synthesis, tetracycline 
Doxycycline 267  protein synthesis, tetracycline 
Chlortetracycline 336  protein synthesis; 30S ribosomal 
subunit; tetracycline 
Demeclocyline 382  protein synthesis; 30S ribosomal 
subunit; tetracycline 
Rolitetracycline 166  protein synthesis, 30S ribosomal 
subunit, tetracycline 
Erythromycin 663  protein synthesis; 50S ribosomal 
subunit; macrolide 
Oleandomycin 693  protein synthesis, 50S ribosomal 
subunit, macrolide 
Troleandomycin 118  protein synthesis, macrolide 
Kanamycin 127  protein synthesis; 30S ribosomal 
subunit; aminoglycoside 
Neomycin 323  protein synthesis; 30S ribosomal 
subunit; aminoglycoside 
Paromomycin 130  protein synthesis, aminoglycoside 
Sisomicin -94 -85 protein synthesis, aminoglycoside 
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Table S3.1 (continued) 
Chlorpromazine  -127 phenothiazine 
Chelerythrine  -81 protein kinase C 
 
Nutrient source 
Ala-Ala-Ala -36 -32 N-source 
D-Ala-Leu  -35 N-source 
Ala-Gln -44  N-source 
Ala-His -31  N-source 
D;L-a-Amino-N-
Butyric Acid 
-39  N-source 
Gly-Gly-Leu -33 -31 N-source 
Gly-Met -32  N-source 
Leu-Asp  -33 N-source 
L-Ile -58  N-source 
L-Ornithine -33  N-source 
L-Trp -30  N-source 
Lys-Ala -43 -39 N-source 
Lys-Leu -31 -34 N-source 
Lys-Val -39  N-source 
Met-Pro  -37 N-source 
Phe-Ile -38  N-source 
Phe-Trp -31 -31 N-source 
Pro-Ala  -35 N-source 
Pro-Leu -32 -53 N-source 
Pro-Pro -42 -31 N-source 
Pro-Tyr -52 -39 N-source 
Ser-Leu -43 -53 N-source 
Ser-Met -34 -32 N-source 
Ser-Phe -45 -41 N-source 
Ser-Ser -42  N-source 
Ser-Tyr -46 -30 N-source 
Ser-Val -40  N-source 
Thr-Ala -49 -50 N-source 
Thr-Arg -54 -42 N-source 
Thr-Gln -33 -37 N-source 
Thr-Gly -32 -31 N-source 
Thr-Met -37 -37 N-source 
Thr-Pro -37  N-source 
Trp-Ala -50 -50 N-source 
Trp-Arg -47 -47 N-source 
 
 115 
 
 
 
 
Table S3.1 (continued) 
Trp-Asp -52 -53 N-source 
Trp-Glu -49 -50 N-source 
Trp-Gly -41 -44 N-source 
Trp-Lys -32 -32 N-source 
Trp-Ser -37 -42 N-source 
Trp-Trp -58 -50 N-source 
Trp-Tyr -39 -39 N-source 
Tyr-Ala -45 -33 N-source 
Tyr-Gln -45 -42 N-source 
Tyr-Glu -36 -35 N-source 
Tyr-Gly -38 -30 N-source 
Tyr-His -37 -33 N-source 
Tyr-Leu -52 -53 N-source 
Tyr-Phe -48 -39 N-source 
Tyr-Tyr -34 -34 N-source 
Val-Asn -34 -45 N-source 
Val-Asp -48 -31 N-source 
Val-Gly -53 -52 N-source 
Val-Ile -57 -49 N-source 
Val-Leu -45 -48 N-source 
Val-Tyr -37 -44 N-source 
Val-Tyr-Val -38  N-source 
Val-Val -46 -44 N-source 
a. Compounds that are subjected to further susceptibility with disk diffusion assays are noted 
by *.   
b. Growth measurements were done using cell respiration indicator as described in Methods 
and Materials. Negative values indicate significantly poorer growth of the mutant strain 
relative to 168 while positive values indicate better growth of the mutant strain relative to 168. 
c. Possible effect or mode of action (original Biolog annotation). Of note, not all modes of 
action are applicable to B. subtilis. 
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CHAPTER 4 
ANALYSIS OF THE ROLE OF BACILLUS SUBTILIS SIGMA M IN β-LACTAM 
RESISTANCE REVEALS AN ESSENTIAL ROLE FOR C-DI-AMP IN 
PEPTIDOGLYCAN HOMEOSTASIS 
The Bacillus subtilis extracytoplasmic function (ECF)  factor M is inducible by, and 
confers resistance to, several cell envelope acting antibiotics. Here, we demonstrate 
that M is responsible for intrinsic β-lactam resistance, with X playing a secondary 
role. Activation of M upregulates several cell wall biosynthetic enzymes including 
one, PBP1, shown here to be a target for the beta-lactam cefuroxime. However, M 
still plays a major role in cefuroxime resistance even in cells lacking PBP1. To better 
define the role of M in β-lactam resistance we characterized suppressor mutations that 
restore cefuroxime resistance to a sigM null mutant. The most frequent suppressors 
inactivated gdpP (yybT) which encodes a cyclic-di-AMP phosphodiesterase (PDE). 
Intriguingly, M is a known activator of disA encoding one of three paralogous c-di-
AMP cyclases (DAC). Overproduction of the GdpP PDE greatly sensitized cells to β-
lactam antibiotics. Conversely, genetic studies indicate that at least one DAC is 
required for growth with depletion leading to cell lysis. These findings support a 
model in which c-di-AMP is an essential signal molecule required for cell wall 
homeostasis. Other suppressors highlight the roles of ECF  factors in counteracting 
the deleterious effects of autolysins and reactive oxygen species in β-lactam treated 
cells. 
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The results of this study were published in Luo Y and Helmann JD. Molecular 
Microbiololgy. 2012 Feb; 83(3):623-39.  
4.1 Introduction 
 The bacterial cell envelope is crucial for maintaining cell shape and 
counteracting turgor pressure and is an important target for many antimicrobial 
compounds (85). The cell envelope of Bacillus subtilis contains a cytoplasmic 
membrane surrounded by layers of cross-linked peptidoglycan (PG), membrane-
associated lipoteichoic acids (LTA), and wall-associated teichoic acids (WTA) (23, 
78). PG is a polymer of alternating N-acetylglucosamine (NAG) and N-acetylmuramic 
acid (NAM) glycan chains cross-linked by peptide sidechains. The newly synthesized 
lipid-linked NAG-NAM units are polymerized to glycan strands by the action of 
transglycosylase (TG). Concurrent with, or soon after this polymerization, the peptide 
side chains on the NAM residue are cross-linked by transpeptidase (TP). Both TG and 
TP are activities of high molecular weight penicillin binding proteins (HMW PBPs), 
and they are the targets of moenomycin and the -lactam antibiotics, respectively (23, 
53, 86). 
 β-lactam antibiotics are characterized by the presence of a β-lactam ring which 
mimics the D-Ala-D-Ala dipeptide substrate of HMW PBP and inhibits the 
transpeptidation reaction by covalent modification of the TG active site (53). This 
inhibition disrupts cell wall biosynthesis, triggers the formation of reactive oxygen 
species (ROS), and results in cell lysis and death (32, 45, 46). Synthesis and 
incorporation of new PG glycan strands into the existing cell wall requires close 
 118 
coordination between the biosynthetic machinery (including HMW-PBPs) and 
autolytic enzymes that allow the separation of already crosslinked glycan strands. 
When properly coordinated, the cell grows normally and maintains proper cell shape. 
Conversely, agents that prevent this coordination by inhibiting TG or TP activities of 
PBPs, or by activating autolysins, lead to lysis and cell death (Figure 4.1). Several 
models have been advanced to explain how this coordination occurs, but the existence 
and precise architecture of the proposed biosynthetic holoenzyme is still unclear (9, 
84). 
 There are three major mechanisms that confer high level β-lactam resistance as 
described for the Gram positive genera Staphylococcus and Streptococcus and the 
Gram negative species Escherichia coli and Pseudomonas spp. These are: (i) 
expression of β-lactamase(s) that inactivate the antibiotics; (ii) expression of mutated 
or mosaic PBP alleles that have low affinity for β-lactams; and (iii) the expression of a 
β-lactam specific efflux pump (67, 87). B. subtilis displays a significant level of 
intrinsic resistance against a variety of β-lactam antibiotics, but the underlying 
mechanisms are poorly understood. Although there are three putative β-lactamase 
genes (penP, ybbE, and yblX) in the genome, no β-lactamase activity is detected in the 
growing cells or supernatant (16). No penicillin-insensitive PBP alleles have been 
identified nor does an efflux pump-based mechanism appear to be applicable to B. 
subtilis and other Gram positive bacteria. Therefore, the molecular basis of this 
intrinsic, moderate level β-lactamase resistance is unclear. Recent results suggest that 
extracytoplasmic function (ECF)  factors play a role in resistance to β-lactam 
antibiotics: a triple mutant (strain sigMWX) as well as a mutant lacking all 7 ECF σ  
 Figure 4.1. 
σX to cell w
acetylmuram
glycan chai
(TP) and are
the transgly
TP-mediate
(see text), in
pathways as
reactive ox
indirect pos
Model of pe
all antibioti
ic acid an
ns. Peptide 
 broken by 
cosylation (
d crosslinkin
dicate that 
 shown on t
ygen specie
itive regulat
ptidoglycan
c resistance
d N-acetyl
crosslinks b
autolytic en
TG) step in
g. The resu
σM and σX 
he right. Ge
s; straight 
ion; ―| nega
119 
 (PG) home
. The altern
glucosamin
etween stra
dopeptidase
 glycan ch
lts reported 
contribute to
nes identifie
arrow, dire
tive regulat
ostasis and 
ating grey a
e, respectiv
nds are intr
s (black tria
ain elongati
herein, com
 antibiotic 
d by Tn7 m
ct positive 
ion.
the contribu
nd white ba
ely, which
oduced by t
ngle). Moen
on while ß-
bined with p
resistance b
utagenesis a
regulation; 
tions of σM
rs represent
 comprise 
ranspeptida
omycin targ
lactams inh
revious res
y three dist
re boxed. R
dashed arr
 
 
and 
 N-
the 
tion 
ets 
ibit 
ults 
inct 
OS, 
ow, 
 120 
 factors (strain Δ7ECF) is sensitive to β-lactam antibiotics including ampicillin, 
penicillin G, aztreonam, and cefuroxime (51, 55). 
B. subtilis harbors 7 ECF σ factors, σM, σX, σW, σV, σY, σZ and σYlaC. Of these, 
the physiological roles of σM, σW, σX, and more recently σV, have been well 
characterized, and their target regulons have been defined (21, 30, 35, 41). Both 
expression and activity of these ECF σ factors are often stimulated by cell wall-active 
antibiotics. M is strongly induced by vancomycin and moenomycin, and confers 
resistance to moenomycin (21, 55, 83). Activation of the σW regulon contributes to 
resistance to fosfomycin, sublancin, and a toxic peptide SdpC (5, 8). The σX regulon is 
involved in the resistance to nisin and other cationic antimicrobial peptides (6, 7). 
Finally, σV is induced by and provides resistance to lysozyme (30, 36).   
 In this study, we investigated the roles of ECF σ factors in providing intrinsic 
resistance to β-lactam antibiotics and, in particular, to cefuroxime (CEF). We found 
that σM plays a primary role in β-lactam resistance, with σX as a secondary determinant. 
We identified Tn7 insertions mutations that restored CEF resistance to a sigM mutant. 
Genetic analysis reveals a central role for the recently identified signal molecule 
cyclic-di-AMP (c-di-AMP), synthesized in part by a M-activated diadenylate cyclase 
(DAC), in cell wall homeostasis. In addition, our results highlight the key role of 
previously defined pathways by which ECF σ factors regulate autolysin activity and 
resistance to reactive oxygen species.  
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4.2 Material and Methods   
Bacterial strains and growth conditions. B. subtilis strains used are derivatives of 
strain168 (trpC2) and are shown in Table 4.1. Escherichia coli strain DH5 was used 
for standard cloning procedures. Bacteria were grown in Luria-Bertani (LB) (10 g 
tryptone, 5 g yeast extract and 5 g NaCl per liter) broth at 37oC with vigorous shaking. 
Antibiotics were added to the growth medium when appropriate: 100 g/ml ampicillin 
for E. coli, and 1 g/ml erythromycin plus 25 g/ml of lincomycin (MLS, macrolide-
lincomycin-streptogramin B resistance), 10 g/ml chloramphenicol, 100 g/ml 
spectinomycin (Spc), 5 µg/ml tetracycline and 10 g/ml kanamycin for B. subtilis. 
OD600 readings were taken on a Spectronic 21 spectrophotometer.  
Strain Constructions. Gene deletions were generated by replacing the coding region 
with an antibiotic resistance cassette using long flanking homology PCR (LFH-PCR) 
followed by DNA transformation as previously described (56). Chromosomal DNA 
transformations were performed as described previously (34). 
The IPTG inducible constructs were generated using vector pPL82 (70). PCR 
products were amplified from B. subtilis 168 chromosomal DNA, digested with 
endonucleases, and cloned into pPL82. pPL82 contains a chloramphenicol resistance 
cassette, a multiple cloning site downstream of the Pspac(hy) promoter, and the lacI gene 
between the two arms of the amyE gene.  Primer pairs used for PCR amplification are 
5249/5250 for disA, 5252/5253 for ybbP, 5255/5256 for yojJ, 5244/5245 for gdpP, 
and 5244/5258 for gdpP1-303.  All oligonucleotide sequences are listed in SI Table S1. 
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The sequences of the inserts were verified by DNA sequencing (Cornell DNA 
sequencing facility). pPL82- gdpPD420A was generated using overlap joining PCR with  
pPL82-gdpP as DNA template. Primer pairs 5244/5293, and 5294/5245 were first 
used to amplify the up and down fragments of gdp, respectively. The gdpPD420A 
mutation was generated using primers 5293 and 5294. A joining PCR was then 
performed with the up and down fragments as template and primer pairs 5244/5245. 
The PCR product was cloned into pPL82 as above, and the insert was verified by 
DNA sequencing. Plasmids were linearized by ScaI and used to transform B. subtilis, 
where they integrated into the amyE locus. 
  
 123 
 
 
 
 
 
 
 
Table 4.1. Strains used in this study  
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Strain1  Genotype  Reference / construction2 
168 trpC2 lab strain 
CU1065 trpC2 attSPβ lab strain 
PS832 Prototrophic revertant of strain 168 lab strain 
BSU2007 168 sigMWXYZV ylaC  (Δ7ECF) (1) 
HB0031  CU1065 sigM::kan (8) 
HB10216 168 sigM::kan chrDNA of HB0031 -->168 
HB10016 168 sigM::tet (52) 
HB10103 168 sigX::kan (52) 
HB10102 168 sigW::mls (52) 
HB10114 168 sigX::kan, sigW::mls (52) 
HB10117 168 sigM::tet, sigW::mls (52) 
HB10113 168 sigM::tet sigX::kan (52) 
HB7007 CU1065 sigX::spc (37) 
HB15815 168 sigM::kan sigX::spc chrDNA of HB7007 --> HB10216 
HB10107 168 sigM::tet, sigX::kan sigW::mls (52) 
HB10236 168 sigZ::kan sigV::cat sigY::mls ylaC::spc (51) 
HB5421 CU1065 amyE::PsigX-lacZ cat Lab strain 
HB5422 CU1065 amyE::PsigW-lacZ cat Lab strain 
HB5423  CU1065 amyE::PsigM-lacZ cat Lab strain 
HB10183 168 amyE::PsigM-lacZ cat chrDNA of HB5423 --> 168 
HB10184 168 amyE::PsigX-lacZ cat chrDNA of HB5421 --> 168 
HB10185 168 amyE::PsigW-lacZ cat chrDNA of HB5422 --> 168 
PS2062 PS832 ponA::spc (68) 
HB10386 168 ponA::spc chrDNA of PS2062 --> 168 
HB0047 CU1065 rsiX::spc lab strain 
HB10118 168 rsiX::spc chrDNA of HB0047 --> 168 
HB10379 168 sigM::tet rsiX::spc chrDNA of HB10118 --> HB10016
HB10536 CU1065 sigX rsiX::kan LFH -->CU1065 
HB10378 168 sigM::tet sigX rsiX::kan chrDNA of HB10536 -->HB10016 
HB10131 168 abh::spc (52) 
HB4728 CU1065 spx::spc lab strain 
HB10328 168 spx::spc chrDNA of HB4728 --> 168 
HB10348 168 spx::mls LFH -->168 
HB10329 168 sigM::kan spx::spc chrDNA of HB4728 --> HB10216 
HB15808 168 sigM::kan abh::spc chrDNA of HB10131 --> HB10216
HB15811 168 sigM::kan abh::spc spx::mls chrDNA of HB10348--> HB15808 
HB10316 168 clpP::tet LFH-->168 
HB10332 168 spx::spc clpP::tet chrDNA of HB10316 --> HB10328
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Table 4.1 (continued) 
HB10320 168 sigM::kan clpP::tet chrDNA of HB10316 --> HB10216 
HB15814 168 sigM::kan spx::spc clpP::tet chrDNA of HB10316 --> HB10329 
HB15816 168 sigM::kan sigX::spc clpP::tet chrDNA of HB10316 --> HB15815 
HB15823 168 sigM::kan sigX::spc spx::mls  chrDNA of HB10348 --> HB15815 
HB15824 168 sigM::kan sigX::spc spx::mls clpP::tet chrDNA of HB10316 --> HB15823 
HB10278 168 amyE:: Pspac(hy)- gdpP cat pPL82-gdpP -->168 
HB10287 168 amyE::Pspac(hy)- gdp1-303 cat pPL82-gdpP1-303 -->168 
HB10309 168 amyE::Pspac(hy)- gdpPD420A cat pPL82- gdpPD420A -->168 
HB10352 168 gdpP::mls LFH -->168 
HB10257 168 sigM::kan gdpP::mls chrDNA of HB10352 --> HB10216 
HB10295 168 sigM::kan gdpP::mls amyE::Pspac(hy)- 
gdpP cat 
chrDNA HB10278--> HB10257 
HB10298 168 sigM::kan gdpP::mls  amyE::Pspac(hy)- 
gdpP1-303 cat 
chrDNA HB10287 --> HB10257 
HB10310 168 sigM::kan gdpP::mls  amyE::Pspac(hy)- 
gdpPD420A cat 
chrDNA HB10309 --> HB10257 
HB10353 168 disA::spc LFH -->168 
HB10334 168 ybbP::tet LFH -->168 
HB10335 168 yojJ::kan LFH -->168 
HB10365 168 disA::spc  amyE:: Pspac(hy)- gdpP cat chrDNA of HB10278 --> HB10353 
HB10366 168 ybbP::tet amyE:: Pspac(hy)- gdpP cat chrDNA of HB10278 --> HB10334 
HB10367 168 yojJ::kan amyE:: Pspac(hy)- gdpP cat chrDNA of HB10278 --> HB10335 
HB10354 168 disA::spc yojJ::kan chrDNA of HB10353 -->HB10335 
HB10356 168 ybbP::tet yojJ::kan chrDNA of HB10334 -->HB10335 
HB10281 168 amyE::Pspac(hy)-disA cat pPL82-disA -->168 
HB10283 168 amyE::Pspac(hy)-ybbP cat pPL82-ybbP -->168 
HB10285 168 amyE::Pspac(hy)-yojJ cat pPL82-yojJ -->168 
HB10357 168 disA::spc amyE:: Pspac(hy)-disA cat chrDNA of HB10353 --> HB10281 
HB10358 168 ybbP::tet amyE:: Pspac(hy)-ybbP cat chrDNA of HB10334 --> HB10283 
HB10374 168 ybbP::tet amyE:: Pspac(hy)-yojJ cat chrDNA of HB10334 --> HB10285 
HB10359 168 disA::spc ybbP::tet amyE:: Pspac(hy)-
ybbP cat 
chrDNA of HB10353 --> HB10358 
HB10360 168 disA::spc ybbP::tet amyE:: Pspac(hy)-
disA cat 
chrDNA of HB10334 --> HB10357 
HB10375 168 disA::spc ybbP::tet amyE:: Pspac(hy)-
yojJ cat  
chrDNA of HB10353 --> HB10374 
HB15802 168 ybbP::tet yojJ::kan amyE:: Pspac(hy)-
ybbP cat  
chrDNA of HB10358 --> HB10356  
HB15803 168 ybbP::tet yojJ::kan amyE:: Pspac(hy)-
yojJ cat  
chrDNA of HB10374 --> HB10356  
HB15801 168 disA::spc ybbP::tet yojJ::kan amyE:: 
Pspac(hy)--disA cat  
chrDNA of HB10354 --> HB10360  
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Table 4.1 (continued) 
HB15806 168 disA::spc ybbP::tet yojJ::kan amyE:: 
Pspac(hy)-ybbP cat  
chrDNA of HB10353 --> HB15802 
HB15807 168 disA::spc ybbP::tet yojJ::kan amyE:: 
Pspac(hy)-yojJ cat  
chrDNA of HB10353 --> HB15803 
HB10209 168 sigM::tet spo0A::Tn7 WT Tn7 library --> HB10016 
HB10210 168 sigM::tet tagA::Tn7 WT Tn7 library --> HB10016 
HB10253 168 sigM::kan gdpP::Tn7 sigM::kan Tn7 library --> HB10216 
HB10247 168 sigM::kanrsiX::Tn7 sigM::kan Tn7 library --> HB10216 
HB10248 168 sigM::kan lytE::Tn7 sigM::kan Tn7 library --> HB10216 
HB10246 168 sigM::kan pbpX::Tn7 sigM::kan Tn7 library --> HB10216 
HB10273 168 sigM::kan ymdB::Tn7 sigM::kan Tn7 library --> HB10216 
HB10249 168 sigM::kan kinD::Tn7 sigM::kan Tn7 library --> HB10216 
HB10245 168 sigM::kan qoxAB:Tn7 sigM::kan Tn7 library --> HB10216 
HB10274 168 sigM::kan ssrA::Tn7 sigM::kan Tn7 library --> HB10216 
HB10263 168 sigM::kan gdpP::mls lytE::Tn7 sigM::kan Tn7 library --> HB10257 
HB10264 168 sigM::kan gdpP::mls clpP::Tn7 sigM::kan Tn7 library --> HB10257 
1 Some genes have multiple Tn7 insertion positions. Only one representative strain number for 
each gene is listed here.  
2 The donor DNA and recipient strain of transformation are indicated before and after the 
arrows, respectively. 
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Antibiotic susceptibility tests. Susceptibility tests for antibiotics were conducted 
using disk diffusion assay and minimal inhibitory concentration (MIC) test. Mueller 
Hinton (MH, Sigma-Aldrich) medium was used for both assays. Disk diffusion assays 
were performed as previously described (51). The bottom agar is 15 ml MH broth 
supplemented with1.5% agar, and the top agar is 4 ml MH broth supplemented with 
0.75% agar.  We used BBL™ Sensi-Disc™ Susceptibility Test Discs (BD; cefixime 5 
µg, cefoxitin 30 µg, ceftriaxone 30 µg, ceftazidime 30 µg, cefoperazone 75 µg, 
amoxicillin 30 µg, ampicillin 10 µg, piperacillin 100 µg, oxacillin 1 µg, piperacillin 
100 µg, imipenem 10 µg, meropenem 10 µg, and Isoniazid 1µg) and also prepared 
disks using Whatman filter paper disks (7 mm in diameter) and freshly made stocks of 
antibiotics (aztreonam 30 µg, cefuroxime 6 µg , penicillin G 10 U, nalidixic acid 30 
µg, novobiocin 250 µg, vancomycin 30 µg, polymycin B 250 µg, and moenomycin 50 
µg). The zone of growth inhibition was measured after overnight growth at 37°C. For 
MIC test, fresh single colonies were first grown in MH broth to an OD600 of 0.4, and 
diluted 1:100 in MH broth, and 200 µl of the diluted culture was dispensed in 
Bioscreen 100-well microtiter plate. Growth was measured spectrophotometrically 
(OD600) using a Bioscreen incubator (Growth Curves USA, Piscataway, NJ) at 37°C 
with vigorous shaking. The absorbance was recorded every 30 minutes for 24 hours. 
Inhibition was defined as a final OD600<0.2 at the 12 hour time point (after 12 h, 
suppressor mutants started to grow up). All antibiotics susceptibility tests were 
performed with biological triplicates and repeated at least twice. 
Bocillin-FL competitive labeling assay. The bocillin-FL labeling assay was 
performed as previously described (42, 91) with modifications. Overnight cultures of 
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B. subtilis cells in LB were diluted 1:100 into 5 ml fresh LB broth, and incubated at 
37°C with vigorous shaking. When cell cultures reached mid-log phase (OD600 0.4), 
the cultures were treated with either 0.05 µg/ml (final conc.) of bocillin-FL, or with 
additional challenge of 0.00625µg/ml (final conc.) of CEF, or an additional 5 µg/ml 
aztreonam (final conc.) for 10 min. The cells were pelleted by centrifugation and kept 
at -20°C overnight. The pellet was thawed on ice and resuspended in 50 µl 0.85% 
NaCl. The cell resuspension was boiled for 5 min with SDS loading buffer, and 
proteins were separated by 4~12% SDS-PAGE. To visualize the labeled PBPs, the 
gels were scanned with a Molecular Dynamics Typhoon PhosporImager (excitation at 
488 nm and emission at 530 nm), and the images were analyzed using ImageQuant TL 
(Amersham Biosciences).  
Tn7 mutagenesis. The Tn7 mutagenesis libraries were generated with chromosomal 
DNA using in vitro transposition as described (4). The library DNA was transformed 
into WT B. subtilis or a sigM mutant strain (HB10216), and the resulting transposants 
were grown in the presence of 100 µg/ml spectinomycin (Spc) with and without xylose 
(final concentration  of 1%). Chromosomal DNA was prepared from these cultures 
using phenol-chloroform extraction (76) and considered an amplified Tn7 library. The 
amplified Tn7 library DNA was transformed into the sigM mutant strains (HB10016 
or HB10216), and cells were plated on LB agar supplemented with 100 µg/ml Spc, 1% 
xylose and 2 µg/ml CEF (32 x MIC of the sigM strain). Resulting transformants were 
streaked onto the same selection plate twice. In order to confirm that the increased 
CEF resistance was due to the presence of the transposon, we performed linkage tests 
by transforming the chromosomal DNA of the Tn7 mutants into the sigM mutant again 
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and selecting with 100 µg/ml Spc. The resulting transformants (20 colonies for each 
strain) were then streaked on LB agar supplemented either with 100 µg/ml Spc or with 
100 µg/ml Spc plus 2 µg/ml CEF. The transformants that can grow on both plates 
were counted as linked mutants, and strains with 100% linkage were subjected to Tn7 
insertion position mapping using arbitrary PCR as previously described (4). The 
dependence on xylose was tested by streaking cells on LB agar supplemented with 2 
µg/ml CEF or with 2 µg/ml CEF plus 1% xylose. Tn7 mutagenesis with strain sigM 
gdpP (HB10257) was performed as described above, except that 4 µg/ml of CEF 
(MIC of the WT strain, and 64 x MIC of the sigM strain) was used for selection.    
β-galactosidase activity test. Strains harboring ECF σ promoter-lacZ fusions were 
grown overnight in LB broth containing appropriate antibiotics and diluted 1:100 into 
5 ml LB medium. The culture was grown at 37oC with vigorous shaking to OD600~0.4 
(mid-log growth phase), and then split into two aliquots. One was challenged with 8 
µg/ml of CEF and the other was untreated. The cultures were returned to 37oC, and 
samples were collected after 30 min. β-galactosidase assays were performed as 
described by Miller (26), and each strain was tested in biological triplicates and 
repeated three times. Data were reported as the mean and SE. 
5' rapid amplification of cDNA ends (5’ RACE). The transcriptional start site of 
ybbP was determined using 5' rapid amplification of cDNA ends (5'-RACE). Five 
micrograms of total RNA from a mid-log-phase LB culture was reversed transcribed to 
cDNA using TaqMan reverse transcription reagents (Roche) and oligo ybbP-rev-GSP3 
(5584) as primer. The 3' end of cDNA was tailed with poly-dCTP using terminal 
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deoxynucleotidyl transferase (New England Biolabs). The tailed cDNAs were then 
amplified by PCR with primers AAP (3314) and ybbP-rev-GSP4 (5585). The PCR 
products were subjected to DNA sequencing (Cornell DNA sequencing facility). 
Growth rate test. Fresh single colonies were first grown in MH broth to OD600 of 0.4, 
and diluted  1:100 in MH broth, and inoculated in Bioscreen microtiter plates with a 
total inoculum of 200 µl. Growth was measured spectrophotometrically (OD600) using 
a Bioscreen incubator (Growth Curves USA, Piscataway, NJ) at 37°C with vigorous 
shaking. The specific growth rate of each strain was calculated from the exponential 
growth phase. Each test was performed with biological triplicates and repeated twice.  
Depeletion of c-di-AMP and microscopic imaging. Strain HB10359 was grown in 
MH broth supplemented with 1mM IPTG to mid-exponential phase, and collected by 
centrifugation. The cells were washed twice with MH medium, and resuspended to 
OD600 of 0.2 in fresh MH broth, or MH broth supplemented with 1mM IPTG, SMM 
(20 mM MgCl2, 10% sucrose, 20 mM maleic acid, pH 7.0), 10% sucrose, or 10mM 
MgSO4. 200 µl of each cell resuspension was added a Bioscreen microtiter plate, and 
incubated at 37°C with vigorous shaking. For phase contrast and fluorescence 
microscopy, 1µg/ml (final concentration) of cell membrane stain FM 4-64 (Invitrogen) 
was added to the cell culture, and incubated at 37 °C for 30min with shaking. 5 µl of 
cells were then mounted on microscope slide coated with a thin film of 1% agarose as 
previously described in (27). Microscopy was performed using an Olympus BX61 
epifluorescence microscope. Images were acquired using Cooke SensiCam and 
Slidebook software (Intelligent Imaging Inc.). 
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4.3 Results and Discussion 
σM is the major ECF σ factor involved in the intrinsic resistance to cefuroxime. 
Previously, we showed that a null mutant lacking all 7 ECF σ factors (strain Δ7ECF) 
has higher sensitivity to numerous antibiotics (including several β-lactams) compared 
to the wild type (WT) strain (51). To clarify the role of ECF σ factors in mediating the 
intrinsic resistance to β-lactam antibiotics, we here sought to identify both the ECF  
factor(s) and the relevant pathways responsible for resistance using cefuroxime (CEF) 
as a model ß-lactam. 
Isogenic strains carrying single or multiple mutations in genes encoding ECF σ 
factors were tested for CEF susceptibility using disk diffusion and minimal inhibition 
concentration (MIC) assays. A sigM null mutant showed elevated sensitivity to CEF, 
whereas other single mutants showed little or no change (Figure 4.2). The double sigM 
sigX mutant displayed high sensitivity equivalent to the Δ7ECF strain. A sigW mutant 
showed no effect, although effects on ß-lactam resistance have been seen in other B. 
subtilis strain backgrounds (49). None of the other four ECF σ factors played a role in 
CEF resistance, even when a multiple mutant strain was tested (Figure 4.2). We 
conclude that σM is the major ECF σ involved in the intrinsic resistance to CEF, with 
σX playing a secondary role apparent in strains lacking σM. These results suggest that 
the major resistance pathway(s) depend exclusively on σM for their expression, with 
one or more additional pathways that can be activated by either σM or σX (as revealed 
in the double sigM sigX mutant). As described previously, several ECF  factor 
promoters can be recognized by more than one ECF  factor (38, 55, 69). As we will 
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Antibiotic resistance pathways are often transcriptionally activated in the 
presence of the cognate antibiotic. ECF  factors typically autoregulate their own 
expressions and we and others have previously characterized the relevant 
autoregulatory promoters (2, 35, 83). We therefore monitored the effect of CEF on 
expression from the autoregulatory promoters for sigM, sigW, and sigX. In each case, a 
2~3 fold induction was observed (Table 4.2). In contrast, low (basal) activity and no 
induction were detected for the other four ECF  factors (sigY, sigV, sigZ, ylaC) (data 
not shown). This induction profile is consistent with prior results demonstrating that 
σM, σX and σW are responsive to cell envelope stress and are activated by an 
overlapping set of inducers (21, 33, 55, 58). 
 
 
Table 4.2. ECF σ promoter activities induced after treatment with 8 µg/ml CEF for 30 
min. Activities (Miller Units) were measured using β-galactosidase assays and the 
means and SE are reported. 
 
Reporter fusion Untreated  CEF treated 
PsigM-lacZ 3.7±0.5 10.1±0.5 
PsigX-lacZ 38.6±1.3 99.7±3.5 
PsigW-lacZ 35.6±1.9 71.3±2.3 
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CEF targets PBP1, 2a, 2b and 4. The M regulon is known to include several 
enzymes involved in various aspects of cell wall synthesis including one HMW PBP 
(PBP1, encoded by ponA) (21). In most cases, M-dependent promoters serve to up-
regulate gene expression in response to stress, but are not solely responsible for 
expression due to the presence of other promoters. In the case of ponA, this gene can 
be transcribed from two promoters: one is σM dependent, and the other is σA-dependent. 
We here hypothesized that one mechanism of resistance might be the M-dependent 
upregulation of PBP1 or other factors involved in assembly or function of cell wall 
biosynthetic complexes.  
 To identify the targets of CEF, we performed bocillin-FL competitive labeling 
assays (42, 91). Five HMW PBPs (PBP1, 2a, 2b, 2c, 4) and one low molecular weight 
penicillin-binding protein (LMW PBP) (PBP5) were detected by bocillin-FL labeling 
and CEF competed with bocillin-FL for binding to PBP1, 2b, 2c and 4 (Figure 4.3). 
Since only six PBPs can be detected in this assay, it is possible that other PBPs are 
also targets for CEF. No differences in either PBP profile or relative affinity for CEF 
binding were apparent in a comparison of the CEF sensitive sigMWX mutant and the 
WT strain using the bocillin-FL labeling assay (data not shown). This suggests that 
mutants lacking ECF  factors are not altered in their CEF susceptibility due to a gross 
change in the levels of PBPs.  
Since PBP1 is a target for CEF, we hypothesized that σM-mediated 
upregulation of PBP1 might contribute to β-lactam resistance. However, deletion of 
ponA did not alter CEF susceptibility (a ponA null mutant and WT have an identical 
zone of inhibition). Thus, upregulation of PBP1 by σM does not appear to be a major 
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Tn7 mutagenesis reveals multiple pathways involved in CEF resistance. To gain 
insights into the pathways contributing to CEF resistance, we performed Tn7 
transposon mutagenesis and selected for mutations that restored CEF resistance to a 
sigM mutant. The Tn7 transposon derivative we used harbors an outward-facing, 
xylose-inducible promoter which thereby allows recovery of both loss of function 
(gene disruption) and gain of function (xylose-dependent up-regulation) mutations (4). 
Insertion libraries were generated in vitro using WT genomic DNA as a target and 
then transformed into competent B. subtilis cells with selection for both the transposon 
(spcR) and CEF resistance. In an initial study, we recovered numerous insertions 
linked to sigM. In these strains, a functional copy of sigM had been co-transformed 
into the recipient cells. Although this result confirms the importance of σM in CEF 
resistance, it was otherwise uninformative. Therefore, all subsequent experiments used 
a Tn7 mutant library generated in a sigM mutant (HB10216) background.  
 A total of 520 CEF resistant colonies were obtained in 10 separate experiments. 
DNA sequence analysis identified 25 unique insertions localized to 10 different genes 
(Table 4.3). All of the insertions increased CEF resistance in a sigM mutant, although 
none restored resistance to WT levels (Table 4.3). The most frequently observed 
insertion occurred in yybT, an ortholog of a gene recently renamed gdpP (see below). 
We therefore performed an additional round of selection, transforming the sigM Tn7 
library into a sigM gdpP double mutant strain (HB10257). This selection led to the 
recovery of insertions in two genes (lytE and clpP). Both triple mutants (sigM gdpP 
lytE::Tn7 and sigM gdpP clpP::Tn7) were at least as CEF resistant as WT (Table 4.3). 
These results indicate that gdpP likely affects a different resistance pathway than lytE 
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and clpP. Although our selection plates contained xylose, in no case was CEF 
resistance dependent on xylose suggesting that in each case we have recovered gene 
disruption mutations that lead to increased CEF resistance.  
 
Table 4.3. Tn7 insertions that can restore CEF resistance in a sigM or a sigM gdpP 
mutant. 
Tn7 
Mutants 
Unique 
insertions 
Gene annotation  Resistance 
to CEFa 
Growth rate 
relative to 
WT (%)b.  
Insertions in a sigM background  
gdpP::Tn7 11 phosphodiesterase ++  98 
rsiX::Tn7 1 anti-σX ++  100 
lytE::Tn7 1 autolysin  ++  98 
pbpX::Tn7 1 penicillin-binding endopeptidase X ++  95 
tagA::Tn7 1 wall teichoic acid biosynthesis ++  81 * 
ymdB::Tn7 1 Regulate expression of SlrR  + 68 * 
kinD::Tn7 1 negative regulator of Spo0A~P +  95 
spo0A::Tn7 2 initiation of sporulation +  102 
qoxAB:Tn7 3 cytochrome aa3-600 quinol 
oxidase 
+  52 * 
ssrA::Tn7 1 transfer-messenger RNA (tmRNA)  + 79 * 
Insertions in a sigM gdpP background  
lytE::Tn7 2 autolysin +++ 96 
clpP::Tn7 2 ATP-dependent Clp protease 
proteolytic subunit 
++++ 81 * 
a The resistance to CEF was tested using disk diffusion assay with biological triplicates, and repeated 
twice. The zone of inhibition (mean ± SE) was used for the score. The resistance level of wt is defined 
as “+++”, and ΔsigM is “-”. 
b The sigM strain has the same growth rate as WT (100%). Strains with noticeably reduced growth rates 
are labeled with *.   
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 Genes identified in this suppressor mutation are involved in a variety of 
pathways and functions (Table 4.3). We categorized them into three groups using two 
criteria:  (i) direct or indirect involvement in cell wall metabolism, and (ii) mild or 
strong effect on CEF resistance. The first group included several insertions that 
inactivated genes directly involved in cell wall metabolism including lytE, pbpX, tagA, 
and ymdB. LytE is a major autolytic endopeptidase in vegetative cells (54, 80). LytE 
interacts with the actin-like protein MreBH along the cylindrical part of cell wall and 
with FtsZ and PBP2b at the division septum. It is, therefore, closely related to cell wall 
synthesis (10). The inactivation of lytE presumably increases ß-lactam resistance by 
delaying cell lysis. PbpX is a LMW PBP that is located at the septum during 
vegetative growth (77). Its function is unknown, although it was shown previously to 
be activated by X (6). YmdB was recently reported to regulate the expression and/or 
activity of a transcriptional regulator SlrR, which in turn affects the activity of both D 
and the regulator of biofilm formation, SinR, and likely indirectly modulates autolysin 
activity (19).  Finally, TagA is a key enzyme in the synthesis of teichoic acids, a major 
component of the cell wall (18, 57). The second and third groups of insertions are not 
directly linked to cell wall homeostasis. The second group, including kinD, spo0A, 
qoxAB and ssrA insertions, had relatively mild effects on CEF resistance. Further 
studies are needed to define the mechanisms of these effects, but in several cases the 
mutant strains grew more slowly than WT strain under our experimental conditions 
and this may contribute to their increased ß-lactam resistance (Table 4.3).  
 Here, we focus on the third group of mutations (gdpP, rsiX, and clpP) for 
further analysis since they resulted in strong CEF resistance and have been linked to 
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σM and its regulon members. We recovered 11 independent insertions within the 1980 
bp coding sequence of gdpP (formerly yybT). GdpP is a transmembrane protein 
containing three functional domains: a heme-binding PAS domain, a degenerate 
GGDEF domain, and a DHH/DHHA1 phosphodiesterase (PDE) domain (71, 72). The 
S. aureus ortholog has recently been renamed GdpP to indicate that it is a GGDEF 
domain protein containing phosphodiesterase (17) and we therefore adopt this same 
designation for B. subtilis. RsiX is the anti-σ factor cognate for σX. We hypothesized 
that the rsiX::Tn7 insertion increased ß-lactam resistance by upregulation of X. Tn7 
insertions in clpP led to the highest level of CEF resistance observed in this study 
(Table 4.3). ClpP is a component of the Clp protease. In B. subtilis, the ClpP 
proteolytic core can pair with any of the three Clp ATPases (ClpX, ClpC and ClpE) 
and form a large hetero-oligomeric Clp protease. Clp protease recognizes and 
degrades a wide range of proteins, including non-native proteins and stress response 
regulators, and it is therefore involved in multiple cell development and stress 
response pathways (24). Here, we present evidence that these three insertion mutations 
affect three inter-related pathways for CEF resistance (Figure 4.1). 
The role of σX in CEF resistance is in part through regulation of abh and spx. We 
hypothesized that the Tn7 insertion in rsiX restored CEF resistance by up-regulation of 
X which, as noted above, plays a secondary role in CEF resistance that becomes 
important in the absence of M (Figure 4.1). As predicted, epistasis experiments 
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indicated that X is downstream of RsiX: a sigM sigX rsiX strain was as sensitive to 
CEF as the sigM sigX strain (Figure 4.4A). 
Since the effect of sigX on CEF resistance is greatly enhanced in a sigM 
mutant background (Figures. 4.2 and 4.4A), we hypothesized that the relevant genes 
involved in CEF resistance can be activated by either σM or σX. The regulons of σM 
and σX have been characterized, and several target promoters have been defined that 
are activated by both ECF  factors (6, 21). We chose six such target operons (abh, 
spx, dltABCDE, lytR, yceCDEF, and bcrC) for further analysis. In a WT background, 
only the spx null mutant showed increased CEF susceptibility. When introduced into 
the sigM null mutant, the abh and spx mutations both increased CEF sensitivity 
(Figure 4.4B). The abh and spx CEF sensitive phenotypes in both sigM and sigMX 
background can be complemented using IPTG-inducible abh or spx alleles, 
respectively (Figures S4.1 and S4.2). These results suggest that spx and abh can 
account for at least part of the role of σX in CEF resistance. We also defined the MIC 
of single and multiple mutant strains of sigM, abh, and spx. Although their differences 
in CEF susceptibility are readily detected in the disk diffusion assay (Figure 4. 4A and 
B), mutant strains of sigMX, sigM abh, sigM abh spx have the same MIC of 0.03 
µg/ml when measured in liquid medium (Table S4.3). We therefore focus here on the 
differences observed on solid medium.  
 Abh is a paralog of AbrB and together these two transition state regulators 
regulate biofilm formation, autolysin activity, and antibiotic production and resistance 
(52, 59, 60, 82). The transcription of abh is dependent on σX and σM, with σX being the 
major regulator (39, 52). Recently, an abh mutant was shown to be sensitive to β-
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lactam antibiotics ampicillin, carbenicillin, and cephalexin (59). Resistance to 
ampicillin was restored by inducing the expression of the transcriptional regulator slrR, 
or by inactivating genes encoding major autolysins (lytC and lytF encoding amidase 
and DL-endopeptidase, respectively) (59). These results support a model (Figure 4.1) 
in which Abh indirectly activates the expression of SlrR (60). SlrR forms a 
heteromeric complex with SinR which represses both the lytABC and lytF operons 
(12). Thus, X and M play partially redundant roles in ß-lactam resistance by 
activating Abh, which in turn activates SlrR to enable repression of autolytic enzymes.  
Accumulation of Spx can increase CEF resistance. Next, we investigated the 
genetic basis for increased CEF resistance in the clpP mutant strains. Several of the 
reported phenotypes of clpP mutants have been linked to increased accumulation of 
Spx (62, 63), a global regulator of oxidative stress responses (92). There are at least 
four promoters that control expression of Spx, including one activated by M and σX 
(21). Previously, we determined that spx was transcriptionally activated ~3-fold by 
vancomycin in a M-dependent manner (21) and a similar induction was also reported 
by Jervis et al. using lacZ-fusions (41). Other cell wall antibiotics also induce the Spx 
regulon including amoxicillin (21, 40) and enduracidin (75). 
 β-lactam antibiotics trigger the production of ROS (32, 46), and Spx is known 
to protect against oxidative stress (15, 63, 66, 90). We therefore hypothesized that the 
upregulation of Spx by M might provide a pathway by which ECF  factors 
contribute to antibiotic resistance (Figure 4.1). Indeed, in S. aureus mutation of the 
adaptor protein YjbH was recently found to lead to a modest increase in β-lactam 
resistance which may be due to stabilization of Spx (29).  
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 We used a genetic approach to explore the role of ClpP and Spx in ß-lactam 
resistance. As noted above (Table 4.3), a clpP::Tn7 mutation greatly increased CEF 
resistance in the sigM gdpP mutant strain (HB10264). The clpP null mutation also 
increased CEF resistance in WT and null mutant strains of sigM and both sigM and 
sigX (Figure 4.4C). Spx is a ClpXP substrate (64). The spx mutation masked the effect 
of clpP in the WT, sigM, and sigM sigX strain backgrounds (Figure 4.4C). These 
epistasis results imply that spx is downstream of clpP in the CEF resistance pathway 
and is the major ClpP substrate that plays a role in ß-lactam resistance. Thus, we 
predict that the major impact of the clpP mutation is to enhance accumulation of Spx 
in the cell. To test this idea, an IPTG inducible copy of spx or spxDD (a Clp protease 
insensitive variant; (63)) was introduced in the sigM and sigM sigX mutant strains. An 
increase in CEF resistance was observed when either spx or spxDD was induced 
(although the effect was much more dramatic with the protease-insensitive allele), 
suggesting that the accumulation of Spx can increase resistance to CEF in B. subtilis 
(Figure S4.2). In addition, we performed disk diffusion assays with strains lacking 
either clpX or clpC (Figure S4.3). Deletion of clpX can strongly increase CEF 
resistance in both strain backgrounds of WT and sigM mutant, while deletion of clpC 
only showed minor effect. This result is consistent with the major role of ClpP in CEF 
resistance being the ClpXP-dependent degradation of Spx. 
We also note that the effect of the clpP mutation may not be limited to 
enhancing accumulation of Spx, since mutation of clpP also led to a small increase in 
CEF resistance in a spx mutant background. This effect was most notable in strains 
mutant for sigM or sigM and sigX (Figure 4.4C). A small increased in CEF resistance 
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was also found with a clpC mutant (Figure S4.3). Therefore, we suggest that there are 
other ClpP protease substrates that also contribute, albeit modestly, to CEF resistance. 
One candidate is SlrR which, as noted above, has been implicated in the down-
regulation of autolysins and is subjected to degradation by ClpCP (11) (Figure 4.1). A 
second candidate and a ClpCP-degraded substrate is MurAA. MurAA is a UDP-N-
acetylglucosamine 1-carboxyvinyltransferase, which catalyzes the first committed step 
in PG biosynthesis (44).  
c-di-AMP as an emerging second messenger found in Bacteria. The most frequent 
insertions recovered in our selection (Table 4.3) were in gdpP and inactivate a PDE 
known to degrade c-di-AMP, an emerging second messenger found in Bacteria and 
likely in Archaea (73). c-di-AMP was discovered as a metabolite bound in the crystal 
structure of DisA which catalyzes its synthesis from ATP (88). DisA was initially 
characterized as a DNA integrity scanning protein that signals the integrity of the 
DNA and thereby enables sporulation to proceed (3). This led to a model in which the 
DisA diadenylate cyclase (DAC; DUF147 domain) signals chromosome integrity: 
DAC activity can be strongly inhibited by binding of DisA to branched chain nucleic 
acid structures that might form as recombination intermediates.  
 DisA is the only confirmed c-di-AMP cyclase (DAC) in B. subtilis (65, 88). 
However, B. subtilis encodes two additional candidate DAC proteins (containing 
DUF147 domains): YbbP and YojJ (73). The DisA DAC domain is linked to a helix-
hairpin-helix non-specific DNA-binding domain which allows DAC activity to be 
regulated by DNA integrity. In contrast, YbbP is predicted to be membrane-localized 
and YojJ cytosolic, but little is known of how their activities might be regulated. Of 
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relevance to the present study, transcription of disA is regulated by both σA and σM 
(21).  
 The level of c-di-AMP in the cell is controlled by both its rate of synthesis by 
DAC and its degradation by a c-di-AMP specific phosphodiesterase (PDE) (Figure 
4.1). B. subtilis GdpP (formerly YybT) is a c-di-AMP PDE in vitro (71, 72) and in 
vivo (65). In vegetatively growing B. subtilis, 1.7 µM c-di-AMP was measured which 
increased, in a DisA-dependent manner, to near 5 µM early during sporulation. A 
gdpP deletion strain of B. subtilis was shown to have a >4-fold increase in c-di-AMP 
levels in early sporulating cells (65). Similarly, a ~15 fold increase was observed with 
a gdpP mutation in S. aureus (from 2.8 µM to 42.9 µM). In S. aureus, elevated levels 
of c-di-AMP suppress the growth defects associated with an inability to synthesize 
LTA and alter both autolysin expression and the level of PG crosslinking (17).  
In B. subtilis, the synthesis and degradation of c-di-AMP is correlated with ß-
lactam resistance. GdpP is a transmembrane protein with three functional domains: a 
heme-binding PAS domain, a degenerate GGDEF domain, and a DHH/DHHA1 PDE 
domain (71, 72). In accordance with the emerging model of c-di-AMP as a signal 
molecule, we hypothesized that it was the loss of GdpP PDE activity that conferred 
CEF resistance. We therefore complemented the sigM gdpP strain with an IPTG-
inducible GdpP, a truncated GdpP lacking the DHH/DHHA1 domain (GdpP1-303), or a 
mutated GdpP (GdpPD420A) carrying a single amino acid substitution which abolishes 
PDE activity (72). Induction of WT GdpP conferred an extreme CEF sensitivity 
(Figure 4.5). In contrast, neither of the mutant GdpP proteins increased sensitivity to 
CEF (Figure 4.5), suggesting that it is the PDE activity that affects CEF sensitivity.  
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c-di-AMP is essential for cell growth. To gain insights into the relative contributions 
of disA, ybbP, and yojJ to c-di-AMP synthesis we mutated each of these loci 
individually and in combination. Deletion of ybbP resulted in the highest CEF 
sensitivity (as seen in the uninduced sample in Figure 4.6, and MIC of 1 µg/ml, Table 
S4.3). Deletion of yojJ, however, had no effect. Induction of GdpP increased CEF 
sensitivity in all three DAC mutant backgrounds (Figure 4.6). We conclude that YbbP 
is the major DAC contributing to intrinsic β-lactam resistance in growing cells, and 
that both synthesis and degradation of c-di-AMP affects CEF resistance. This result is 
consistent with the recent suggestion that DisA functions primarily in early sporulation, 
with a comparatively minor contribution in (unstressed) vegetative phase cells (65). It 
is interesting to note that YbbP and GdpP are both membrane-localized, although the 
signals that might control their synthesis and activity are unknown.  
 The expression of YbbP is poorly characterized, but it is noteworthy that it is 
encoded immediately downstream of the sigW-rsiW operon and it may be, in part, 
activated by W.  However, W has no effect in CEF resistance in our B. subtilis WT 
strain background (Figure 4.2). We therefore asked whether σM or σX have a role in 
regulating ybbP. Multiple null mutants of sigM, sigX, and ybbP were constructed and 
tested for their susceptibilities to CEF. The mutation in ybbP is clearly additive to both 
sigM and sigX mutations (Figure S4.4). In addition, the transcriptional start site of 
ybbP was mapped to 72 bp upstream of its start codon using 5’RACE. A σA promoter 
is present upstream of the assigned start site 
(TTCACTtgctaaatcgaaatgtggTATAATgggctcG; upper case letters indicate the -35, -
10, +1 regions, respectively). Together, these results suggest that ybbP is not part of 
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the σM or σX regulatory pathways. 
 We next sought to construct double and triple null mutants of disA, ybbP, and 
yojJ. A disA ybbP double mutant strain could not be obtained, suggesting that this 
combination of mutations is lethal, whereas double mutants of disA yojJ and ybbP yojJ 
were viable. We conclude that c-di-AMP is essential for viability and that the basal 
level of expression of either DisA or YbbP is sufficient to support growth. An 
essential role for DAC proteins has also been suggested in Listeria monocytogenes 
since it was impossible to disrupt the single DAC encoding gene in this organism (89). 
Similarly, DAC genes were identified in screens for essential genes in Mycoplasma 
spp., Streptococcus pneumoniae, and S. aureus (14, 25, 28, 81).   
 To determine whether all three DAC proteins (DisA,YbbP, YojJ) are active 
and could support growth, we integrated an IPTG-inducible copy of each gene into a 
ybbP null mutant and then attempted to introduce a disA null mutation by 
chromosomal transformation. Indeed, a disA ybbP double mutant could be obtained 
when any one of the three genes (disA, ybbP, or yoj) was induced (Figure 4.7A). This 
strategy also allowed construction of IPTG-dependent disA ybbP yojJ triple mutant 
strains in which growth could be supported by any one of three DAC-encoding genes. 
We note that the Pspac(hy) promoter used in this work is slightly leaky and, as a result, 
the disA ybbP Pspac(hy)-disA strain was able to grow even in the absence of IPTG. 
However, the disA ybbP Pspac(hy)-yojJ strain grew slowly and the disA ybbP Pspac(hy)-
ybbP was unable to grow unless at least 50 µM IPTG was present (data not shown). 
These results suggest that all three of these putative DAC proteins are biologically 
active and able to support growth when expressed.  
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The essential role of c-di-AMP is linked to PG homeostasis. Since a reduced level 
of c-di-AMP is linked to high CEF sensitivity, we tested whether c-di-AMP is 
involved in cell wall homeostasis. Depletion of c-di-AMP in strain disA ybbP Pspac(hy)-
ybbP by growth in the absence of inducer IPTG led to cell lysis as monitored both by 
following optical density (Figure 4.7B) and by light microscopy (Figure S4.5). The 
lysis phenotype can be suppressed either by the presence of IPTG (inducing the 
expression of ybbP), or by supplementation of the growth medium with SMM (sucrose, 
MgSO4 and maleic acid), sucrose, or MgSO4. SMM has been used previously to 
stabilize protoplasts and support the growth of cell wall-free L-form cells (13, 47). 
Similarly, sucrose likely functions as an osmotic protectant, and Mg2+ has been shown 
to restore growth and WT morphology of many PG defective mutants including single 
mutants of ponA, rodA, mreB, mreC, mreD, mbl and a double mutant of pbpAH (22, 
42, 43, 48, 61, 79). This is reminiscent of recent results from Corrigan et al.  (17) who 
showed that osmotic protectants support the growth of a LTA deficient mutant of S. 
aureus and that this requirement can be bypassed by a gdpP mutation. The S. aureus 
gdpP mutant displayed an increase in both c-di-AMP and PG cross-linking. 
Collectively, these results suggest that c-di-AMP plays an essential role in PG 
homeostasis (Figure 4.1).  
σM and c-di-AMP are involved in resistance to other cell wall antibiotics. We next 
tested whether c-di-AMP is involved in resistance to other antibiotics. Induction of 
GdpP in strain sigM gdpP Pspac(hy)-gdpP leads to high sensitivity to aztreonam, 
cefixime, and moenomycin in addition to CEF as monitored using disk diffusion 
assays (Figure 4.8). Cefixime is a third generation cephalosporin, aztreonam is a 
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A model for the role of ECF  factors in ß-lactam resistance. The genetic analyses 
presented herein lead to an integrated model in which the ECF  factors M and X 
contribute to ß-lactam resistance by the antibiotic-inducible activation of regulatory 
proteins that affect three distinct pathways (Figure 4.1). B. subtilis PG is a dynamic 
structure, which is continuously synthesized, modified, and hydrolyzed. It is notable 
that M-activated promoters have been previously mapped preceding several genes 
involved in PG synthesis (including mreB, bcrC, divIB, divIC, ddl, murB, murF, rodA, 
pbpX, and ponA), one of the four paralogous LTA synthases (yfnI), and cell wall 
modification enzymes (dltABCDE) (21). Thus, M appears to function to positively 
regulate cell wall assembly and structure in response to antibiotic stress. β-lactam 
antibiotics inhibit the TP activity of PBPs and thereby inhibit glycan strand cross-
linking. This inhibition disrupts the balance between PG synthesis and hydrolysis and 
endogenous autolysins trigger cell lysis. In addition, ß-lactams trigger ROS formation 
and cell death. Both autolysin-dependent and independent mechanisms contribute to 
the bactericidal effect (20, 46).  
ECF  factors counteract the effects of ß-lactams by activating at least three 
distinct pathways (Figure 4.1). First, M contributes to the expression of one of three 
c-di-AMP synthases (DisA). The cellular level of c-di-AMP is regulated by both DAC 
synthases (DisA, YbbP and YojJ) and the cognate PDE (GdpP). At least one DAC is 
required for cell growth, indicating an essential role of c-di-AMP. The cell lysis 
phenotype of our DAC depletion strain together with the recent report from Corrigan 
et al. (17) suggest a positive link between c-di-AMP and PG cross-linking. However, 
the role of c-di-AMP may be not limited to cross-linking, since c-di-AMP also 
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modulates susceptibility to moenomycin, which targets the TG domain of PBP and 
thereby inhibits the polymerization of the PG glycan strands.  
Second, ECF  factors affect the expression and regulation of autolysins. Both 
σM and σX activate the transcription of abh, whose product indirectly activates the 
expression of SlrR, which directly represses expression of LytC and LytF (12, 52, 59). 
Another autolytic endopeptidase (LytE) was identified by Tn7 mutagenesis as a 
contributor to ß-lactam susceptibility. These findings support the notion that 
preventing autolysis can increase ß-lactam resistance.  
Third, our analysis of the ß-lactam resistance phenotype of a clpP null mutant 
identified Spx, a regulator of pathways that protect the cell against ROS (92), as a 
contributor to ß-lactam resistance. The clpP mutant strain may also have elevated 
levels of SlrR, a known inhibitor of autolysin expression (11). Although the model we 
have developed here (Figure 4.1) is already quite complex, it certainly underestimates 
the true complexity of the adaptive responses mediated by ECF  factors and other 
regulators that conspire to protect cells against antibiotics and other chemical insults.  
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4.5 Supplementary Information 
 
 
 
Table S4.1. Oligos used in this study 
# Name Sequence1 
5244 yybT-for(xbaI) GAGTCTAGA CATGGTGGGGAGTGATAGAAATGC 
5245 yybT-rev(bglII) GAGAGATCTTCATCTCTGTACGCCTCCCT 
5258 yybT(1-303aa) 
rev(bglII) 
GAGAGATCTTTAGCCGTTTGGCAGCTTAATG 
5249 disA for(xmaI)  GAGCCCGGGTACTTCATTAGGAGGATAATAGATG 
5250 disA rev(ClaI) GAGATCGATTCATAAGGTTTTAACCGAAATCA 
5252 ybbP for(XmaI) GAGCCCGGGAATCTTGGAGGACGAGGAAATG 
5253 ybbP rev(ClaI) GAGATCGATAGCGGTTGTTTAAGAATTTATCCA   
5255 yojJ for(xmaI)  GAGCCCGGGTTCGTGAAAAGTTGGAAATTTAAACAGGAG 
5256 yojJ rev(ClaI) GAGATCGATTGTCTCATGATAGGATTCTTAATCAG     
5293 yybT D420A up-rev TGTGTAGCAACGATCACAAGCAGTGT  
5294 yybT D420A do-for ACACTGCTTGTGATCGTTGCTACACATAAGCCGTCACTCGT 
5584 ybbP-rev-GSP3  GAACAAGCACGATGACTACA 
5585 ybbP-rev-GSP4  TACCAAACAAGGAGAATATCA 
1 The endonuclease digestion sites are underlined.  
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Table S4.2. Strains used in the supporting information.  
Strain Genotype Reference/ Construction 
JH642 trpC2 pheA1  Lab strain 
PY79 SPβ-cured prototroph strain Lab strain 
BZH73 JH642 abh::kan amyE::Pspac-abh cat 
thrC::sunA'-lacZ spc 
(82) 
HB10158 168  amyE::Pspac-abh cat chrDNA of BZH73 --> 168 
HB10159  168 sigM::tet amyE::Pspac-abh cat chrDNA of HB10158 --> HB10016  
HB15808 168 sigM::kan abh::spc chrDNA of HB10131 --> HB10216 
HB15809 168 sigM::tet abh::spc amyE:: Pspac-abh 
cat 
chrDNA of HB10131 --> HB10159 
HB15810 168 sigM::tet sigX::kan amyE:: Pspac-
abh cat 
chrDNA of HB10103 --> HB10159 
ORB4271 JH642 amyE:: Pspank(hy)-spx spc  (63) 
ORB4342 JH642  amyE: Pspank(hy)-spxDD spc  (63) 
HB10392 168 amyE:: Pspank(hy)-spx spc chrDNA of ORB4271 --> 168 
HB10393 168 amyE:: Pspank(hy)-spxDD spc chrDNA of ORB4342 --> 168 
HB10394 168 sigM::kan  amyE:: Pspank(hy)-spx spc chrDNA of ORB4271 --> HB10216 
HB10395 168 sigM::kan amyE: Pspank(hy)-spxDD spc chrDNA of ORB4342 --> HB10216 
HB15817 168 sigM::kan spx::mls amyE:: Pspank(hy)-
spx spc 
chrDNA of HB10348 --> HB10394 
HB15818 168 sigM::kan spx::mls amyE: Pspank(hy)-
spxDD spc  
chrDNA of HB10348 --> HB10395  
HB15821 168 sigM::tet sigX::kan amyE:: Pspank(hy)-
spx spc 
chrDNA of HB10392 --> HB10113 
HB15822 168 sigM::tet sigX::kan amyE: Pspank(hy)-
spxDD spc 
chrDNA of HB10393 --> HB10113 
HB10372 168 sigM::kan disA::spc chrDNA of HB10216 --> HB10353 
HB10375 168 sigM::kan ybbP::tet chrDNA of HB10216 --> HB10355 
HB10390 168 sigM::kan ybbP::tet sigX::spc chrDNA of HB7007 --> HB10375  
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Table S4.2. (Continued)  
Strain Genotype Reference/ Construction 
RL2774 PY79 clpC::tet (11) 
RL2173 PY79 clpX::spc Win Chai  
HB15839 168 clpC::tet chrDNA RL2774 --> 168 
HB15840 168 sigM::kan clpC::tet chrDNA RL2774 --> HB10216 
HB15841 168 clpX::spc chrDNA RL2173-->168 
HB15842 168 sigM::kan clpX::spc chrDNA RL2173--> HB10216 
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Table S4.3. MIC values of strain 168 and its derivative mutants. 
Strain # Genotype MIC (CEF, µg/ml) 
168 WT 4 
HB10216 sigM::kan 0.06 
HB10113 sigM::tet sigX::kan 0.03 
HB10131 abh::spc 2 
HB10328 spx::spc 3 
HB15808 sigM::kan abh::spc 0.03 
HB10329 sigM::kan spx::mls 0.06 
HB15811 sigM::kan abh::spc spx::mls 0.03 
HB10353 disA::spc 3 
HB10334 ybbP::tet 1 
HB10335 yojJ::kan  4 
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Figure S4.3. Disk diffusion tests with clpP, clpC and clpX mutant in the backgrounds 
of strain WT and sigM mutant and 6 μg CEF. Averages and SE based on three 
biological replicates and two independent experiments are shown. 
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Figure S4.4. ybbP is additive to sigM and sigX in CEF susceptibility. Disk diffusion 
tests were performed with 6 μg CEF. Averages and SE based on three biological 
replicates and two independent experiments are shown. 
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CHAPTER 5 
 CONCLUSIONS AND PERSPECTIVES 
 
B. subtilis expresses seven ECF σ factors. In this dissertation, I have primarily 
characterized strains lacking three of these σ factors (σM, σW and σX) and all seven 
ECF σ factors (σM, σW, σX, σY, σV, σZ and σYlaC). I have also described the mechanism 
by which the ECF σ factors σM and σX regulate the production of sublancin and 
resistance to cefuroxime.  
 In chapter 2, σX and σM are shown to be involved in sublancin production. 
These two σ factors regulate the expression of Abh, which is capable of antagonizing 
repression by AbrB at the sunA promoter, resulting in sublancin production. Sublancin 
is an antibiotic encoded in the lysogenic prophage SPβ. The fact that the chromosome-
located σM and σX can activate the expression of the prophage encoded sublancin, and 
that σW can provide immunity to sublancin(1), suggests an intricate regulatory network 
of antibiotic production and resistance in B. subtilis.   
 In chapter 3, I compared the transcriptomic profiles and phenotypic traits of the 
Δ7ECF and ΔMWX strains to the WT strain. Over 80 genes were found to be, at least 
in part, dependent on ECF σ factors for their transcription. New phenotypes 
(especially increased susceptibility to compounds targeting at cell envelope) were 
found to be associated with these two ECF σ factor deletion strains. In addition, the 
detailed characterization of the Δ7ECF strain in this chapter will facilitate future use 
of this strain. For example, an ECF σ factor can be introduced back into the Δ7ECF 
strain, to test its effect in gene regulation. This type of experiment will allow us to 
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delineate the regulons and function of individual σ factors, without complications due 
to the presence of other ECF σ factors.  
In chapter 4, σM and σX were shown to be involved in cefuroxime resistance 
through three pathways: i) a c-di-AMP pathway that mediates PG homeostasis; ii) a 
Spx pathway that antagonizes ROS damage; and iii) a SlrR pathway that reduces 
expression of autolysins. An important component of this work is the discovery that 
the signaling molecule, c-di-AMP, is essential for cell growth and PG homeostasis. In 
future studies it will be interesting to define those factors regulating both synthesis and 
degradation of c-di-AMP, and to identify the downstream targets of this signaling 
molecule.  
Of the three synthases of c-di-AMP, the expression and activity of DisA is 
regulated by σM and DNA integrity, respectively (5, 7).  There is little known about 
YbbP and YojJ.  YbbP appears to be the major synthase (Chapter 4), and the ybbP 
gene is located downstream of the sigW-rsiW operon, with a possible read-through 
from the sigW promoter. This σW-dependent promoter could be mutated and tested for 
its effect on the transcriptional level of ybbP, especially in the presence of an 
antibiotic stress, such as cefuroxime. 
 GdpP is the only known enzyme that degrades c-di-AMP in B. subtilis. gdpP 
is transcribed as part of an operon under control of A. Tiling array experiments 
revealed an antisense RNA initiated within the gdpP coding region (10). We have 
mapped the start site of this σD-dependent transcript, and found that the expression of 
this transcript can reduce the protein level of GdpP about 3-fold (Data not shown). D 
is known to activate the expression of autolysins in B. subtilis (3, 6). A plausible 
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explanation for the antisense regulation is that D down-regulates gdpP as a 
mechanism to maintain peptidoglycan (PG) homeostasis: the up-regulated PG 
biosynthesis (due to the increased level of c-di-AMP) is concomitant with the 
increased PG degradation (due to the upregulation of autolysins under D control). 
This idea could be tested using a strain carrying a null mutation of the σD promoter yet 
maintaining the amino acid sequence of GdpP. Presumably this mutant strain will not 
be able to down-regulate GdpP synthesis when D is activated and this may lead to an 
imbalance between PG biosynthetic and autolytic functions.  In addition, in vitro work 
has shown that the phosphodiesterase activity of YybT protein can be inhibited by two 
factors, i) the presence of the stringent response alarmone  ppGpp (9), and  ii) the 
binding of heme to the PAS domain of GdpP (8). The biological relevance of these 
two factors, however, needs to be tested in vivo. The heme binding domain of GdpP 
could be mutated and tested whether it could affect the phosphodiesterase activity of 
GdpP. The level of c-di-AMP and ppGpp can be measured directly, using HPLC 
followed by LC-MS/MS (4), and radioactive labeling followed by thin layer 
chromatography (2), respectively. These measurements will allow us to examine 
whether there is coordination between the concentrations of these two molecules. 
Mutation of the ppGpp synthase gene ywaC could also be constructed and tested for 
its effect in c-di-AMP level. 
Although c-di-AMP is clearly essential for growth, the targets of c-di-AMP are 
not yet known in any bacterium. It would be of great interest to identify c-di-AMP 
binding proteins. A feasible method is to use affinity chromatography with a 
biotinylated c-di-AMP (BioLog) as an affinity probe. Proteins associated with c-di-
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AMP can be recovered using streptavidin-sepharose, and further identified by SDS-
PAGE followed by tryptic digestion and MS/MS peptide sequencing. 
In summary, the work presented in this dissertation revealed an important role 
for ECF σ factors in antibiotic production and resistance. Future work with ECF σ 
factors and c-di-AMP can help us understand the complex cell envelope stress 
response mediated by ECF  factors, signaling molecules, and the key components of 
the cell envelope biogenesis machinery. 
  
  
 177 
REFERENCE 
1. Butcher, B. G., and J. D. Helmann. 2006. Identification of Bacillus subtilis 
σW-dependent genes that provide intrinsic resistance to antimicrobial 
compounds produced by Bacilli. Mol Microbiol 60:765-782. 
2. Cavanagh, A. T., P. Chandrangsu, and K. M. Wassarman. 2010. 6S RNA 
regulation of relA alters ppGpp levels in early stationary phase. Microbiology 
156:3791-3800. 
3. Chen, R., S. B. Guttenplan, K. M. Blair, and D. B. Kearns. 2009. Role of 
the σD-dependent autolysins in Bacillus subtilis population heterogeneity. J 
Bacteriol 191:5775-5784. 
4. Corrigan, R. M., J. C. Abbott, H. Burhenne, V. Kaever, and A. Grundling. 
2011. c-di-Amp is a new second messenger in Staphylococcus aureus with a 
role in controlling cell size and envelope stress. PLoS Pathog 7:e1002217. 
5. Eiamphungporn, W., and J. D. Helmann. 2008. The Bacillus subtilis σM 
regulon and its contribution to cell envelope stress responses. Mol Microbiol 
67:830-848. 
6. Marquez, L. M., J. D. Helmann, E. Ferrari, H. M. Parker, G. W. Ordal, 
and M. J. Chamberlin. 1990. Studies of σD-dependent functions in Bacillus 
subtilis. J Bacteriol 172:3435-3443. 
7. Oppenheimer-Shaanan, Y., E. Wexselblatt, J. Katzhendler, E. Yavin, and 
S. Ben-Yehuda. 2011. c-di-AMP reports DNA integrity during sporulation in 
Bacillus subtilis. EMBO Rep 12:594-601. 
8. Rao, F., Q. Ji, I. Soehano, and Z. X. Liang. 2011. Unusual heme-binding 
PAS domain from YybT family proteins. J Bacteriol 193:1543-1551. 
9. Rao, F., R. Y. See, D. Zhang, D. C. Toh, Q. Ji, and Z. X. Liang. 2010. YybT 
is a signaling protein that contains a cyclic dinucleotide phosphodiesterase 
domain and a GGDEF domain with ATPase activity. J Biol Chem 285:473-
482. 
10. Rasmussen, S., H. B. Nielsen, and H. Jarmer. 2009. The transcriptionally 
active regions in the genome of Bacillus subtilis. Mol Microbiol 73:1043-
1057. 
 
